Skip to main content
Erschienen in: Health and Quality of Life Outcomes 1/2017

Open Access 01.12.2017 | Review

The search for relevant outcome measures for cost-utility analysis of systemic family interventions in adolescents with substance use disorder and delinquent behavior: a systematic literature review

verfasst von: S. Schawo, C. Bouwmans, E. van der Schee, V. Hendriks, W. Brouwer, L. Hakkaart

Erschienen in: Health and Quality of Life Outcomes | Ausgabe 1/2017

Abstract

Purpose

Systemic family interventions have shown to be effective in adolescents with substance use disorder and delinquent behavior. The interventions target interactions between the adolescent and involved systems (i.e. youth, family, peers, neighbors, school, work, and society). Next to effectiveness considerations, economic aspects have gained attention. However, conventional generic quality of life measures used in health economic evaluations may not be able to capture the broad effects of systemic interventions. This study aims to identify existing outcome measures, which capture the broad effects of systemic family interventions, and allow use in a health economic framework.

Methods

We based our systematic review on clinical studies in the field. Our goal was to identify effectiveness studies of psychosocial interventions for adolescents with substance use disorder and delinquent behavior and to distill the instruments used in these studies to measure effects. Searched databases were PubMed, Education Resource Information Center (ERIC), Cochrane and Psychnet (PsycBOOKSc, PsycCRITIQUES, print). Identified instruments were ranked according to the number of systems covered (comprehensiveness). In addition, their use for health economic analyses was evaluated according to suitability characteristics such as brevity, accessibility, psychometric properties, etc.

Results

One thousand three hundred seventy-eight articles were found and screened for eligibility. Eighty articles were selected, 8 instruments were identified covering 5 or more systems.

Conclusions

The systematic review identified instruments from the clinical field suitable to evaluate systemic family interventions in a health economic framework. None of them had preference-weights available. Hence, a next step could be to attach preference-weights to one of the identified instruments to allow health economic evaluations of systemic family interventions.
Abkürzungen
AARS
Adolescent Assessment/Referral System
ADAD
Adolescent Drug Abuse Diagnosis
ADI
Adolescent Diagnostic Interview
ASI
Addiction Severity Index
BSFT
Brief Strategic Family Therapy
CAFAS
Child Adolescent Functional Assessment Scale
CBCL
Child Behavior Checklist
CBT
Cognitive Behavioral Therapy
CUA
Cost-utility analysis
EBFT
Ecologically Based Family Therapy
ERIC
Education Resource Information Center
EuroADAD
European Adolescent Assessment Dialogue
FFT
Functional Family Therapy
GAIN
Global Appraisal of Individual Needs
GAIN-SS
Global Appraisal of Individual Needs Short Screener
MDFT
Multidimensional Family Therapy
MET
Motivational Enhancement Therapy
MST
Multisystemic Therapy
POSIT
Problem Oriented Screening Instrument for Teenagers
QALYs
Quality-Adjusted Life-Years

Background

Systemic family interventions are psychotherapeutic treatments, which are increasingly used to treat children and adolescents with mental disorders. These interventions are based on the idea that the behavior of a patient is the result of interactions between himself and the different ‘systems’ he is involved in (i.e. family, peers, school, etc.) and of the interactions between these systems [13]. Treatment is directed at improving the disturbing aspects within these interactions [3] and it actively involves the systemic context of the patient. Hence, potential effects are broad and may range from improvements in the interactions with parents, other family members, peers or neighbors, to improvements in educational achievements and work relations, reduction of criminal activity and substance use and reduction of problems with the juvenile justice system [2, 46]. Systemic family interventions have shown particularly effective in the treatment of adolescents with substance use disorders and delinquency [710]. Examples of these interventions are Multisystemic Therapy (MST), Functional Family Therapy (FFT), Multidimensional Family Therapy (MDFT) and Brief Strategic Family Therapy (BSFT) [710].
With the increasing use of systemic family interventions, the question of funding and reimbursement arises. In some countries, like the Netherlands or the United Kingdom, systemic family interventions are reimbursed from social health insurance schemes and, as such, are part of collectively financed health care. Hence, the interventions compete for limited funds with other health care expenditures and, on top of proving effective, need to demonstrate value for money. Common practice in the economic evaluation of medical interventions is the use of cost-utility analysis (CUA) [11, 12] measuring effects in terms of Quality-Adjusted Life-Years (QALYs). QALYs combine length and quality of life gained. Typically, quality of life is measured through preference-based, generic health outcome measures (such as the EQ-5D). These outcome measures typically concentrate on improvements in a number of health domains. A recent publication of our department [13] described the results of a CUA of MDFT versus Cognitive Behavioral Therapy (CBT) in which the effects were measured with the EQ-5D. Yet, in the field of mental health, doubts have been expressed [14, 15] on the use of these generic quality of life measures [16] as these tools might be too limited to cover all relevant treatment effects. Studies on the applicability of these measures in mental health have presented mixed results [14, 15]. Furthermore, there is increasing attention for the inclusion of spillover effects on caregivers and families in economic evaluations. Currently, these effects are not yet included [17, 18], though they may be particularly important in treatment of younger patients. Recently, the Second Panel of Cost-Effectiveness in Health and Medicine has recommended further research on quality of life effects on family members of patients [19].
Both aspects, the assessment of effects specific to mental health treatments and the inclusion of (partial) effects on third parties, seem of particular relevance to the economic evaluation of systemic interventions in delinquency and substance use in adolescents. As outcomes of systemic family interventions are broad and transcend health gains, conventional CUA outcome measures may be too limited and insufficiently connected to clinical practice. This may be one of the reasons why economic evaluations of systemic interventions are still scarce and overall of low quality [20]. Existing economic evaluations of these interventions vary in setting, design and in outcomes measured [20] hence limiting the comparability of results. Furthermore, few studies consider effects on others than the patient [1].
If the aim is to perform economic evaluations of systemic family interventions which account for all relevant effects, a disorder-specific multidimensional measure that captures all relevant systemic contexts would be desirable. Ideally, if such a measure had societal preference-weights attached to its dimensions and levels, it would deviate from the common CUA methodology yet enable CUA-like economic evaluations. In patients with substance use disorder (one of the patient groups treated with systemic family interventions), the need for such a single comprehensive outcome measure capturing the full benefits of treatments has been recognized before [21]. Deas and Thomas [22] and Hogue and Liddle [23] emphasized the necessity of assessing various outcomes beyond effects in the adolescent. In an illustrative pilot study, Jofre-Bonet and Sindelar [21] presented a first example of a preference-based measure for adult populations with substance abuse. However, that measure was not based on standard preference-elicitation techniques but the authors attached patient preference-weights to the eight main domains of the Addiction Severity Index (ASI) [24] by constructing a weight index.
In the current study, we take this line of research further by searching for a multidimensional outcome measure to evaluate systemic family interventions in the populations of adolescents with substance abuse disorder or problems of delinquency. Such a measure could facilitate CUAs of systemic family interventions and could either be based on existing effectiveness measures in this field or fully designed anew. In both cases, the use of an existing measure or the design of a new measure, relevant domains would need to be identified. Based on consultation of the literature on systemic family interventions [1, 25, 26] the domains relating to aspects of the individual patient, family, school (or work) and other community environments (e.g. peers, neighbors) were considered most relevant to the evaluation of the interventions. Figure 1 provides a graphical illustration of these domains, which indicate where potential effects may occur. The strength of the impact on the different systems may obviously differ, depending on the exact underlying problems and other contextual factors.
We perform a systematic literature review to investigate and appraise available instruments in the field of adolescent delinquency and substance use, which cover the relevant domains and which are already accepted and validated in the field. We assess which of these instruments might be most suited to serve as a basis for a preference-based measure in CUA, based on characteristics like comprehensiveness, brevity, accessibility, psychometric properties, etc. Advantage of using an existing instrument would be its being established, accepted and validated in the field and known by clinicians. It would then only be necessary to add preference-weights to the domains to account for differences in impact of each domain. In this way we aim to contribute to the development of adequate outcome measures to assess the economic value of systemic family interventions in the treatment of delinquency and substance use.

Methods

We conducted a systematic literature review to identify instruments within the effectiveness and efficacy literature of mental health interventions for adolescents with substance use disorder and delinquency problems. We then assessed the suitability of these instruments for use of preference elicitation techniques. The assessment was based on several characteristics relevant to attain societal preference weights. These characteristics were among others the coverage of the systems displayed in Fig. 1 (i.e. youth, family, peers, school, work, society and neighbors), brevity, practicability of use, accessibility, psychometric properties and acceptance in the field. The review protocol was not registered. Yet, this study adhered to the PRISMA reporting guidelines [27].

Criteria for inclusion

Types of participants

The target population of the systematic literature review consisted of adolescents between 12 and 18 years of age with symptoms of delinquency and/or substance use. Patients from specific sub-groups (e.g. homeless or runaway adolescents or adolescents with substance use disorder and comorbid depression) were excluded. As studies focusing on these subgroups evaluated specific outcomes, which were not necessarily relevant for the entire population of adolescents with substance use disorders and delinquent behavior, these studies were not considered relevant for the current study.

Types of interventions

We included studies on various mental health interventions for adolescents with substance use disorder or delinquency in a therapy/counseling setting in the systematic search to cover as many instruments as possible in the relevant target population. Individual interventions as well as systemic family interventions were included. Examples of such interventions are Cognitive Behavioral Therapy (CBT), Motivational Enhancement Therapy (MET), Multidimensional Family Therapy (MDFT), Multi Systemic Therapy (MST), Functional Family Therapy (FFT) and Ecologically Based Family Therapy (EBFT). Two types of interventions were excluded. First, interventions in mental health care that consisted of only pharmacotherapy were excluded since the focus of our study was specifically on the effect of psychosocial interventions. Second, mental health interventions for the prevention of criminal behavior or substance use disorder were excluded, as the symptoms within this group (i.e. high risk behavior or general behavioral problems) were not considered severe enough to fit the definition of the target population.

Types of outcome measures

Our objective was to identify a wide array of instruments used to measure the effect of mental health interventions for adolescents with substance use disorders and delinquent behavior. Hence, we included studies with all measures of effectiveness and treatment outcome as well as efficacy studies.

Search methods for identification of studies

Databases were selected as to cover both interventions in the medical and in the educational field. The systematic literature review was performed in PubMed, Psychnet (PsycBOOKSc, PsycCRITIQUES, print), Cochrane and ERIC (Education Resource Information Center) to identify all effectiveness studies of mental health interventions for adolescent with substance use disorder or problems of delinquency. The databases were consulted between 5 March 2013 and 8 March 2013. Additional studies were identified based on reference list search. There were no restrictions on the type of publication. The language of publication was required to be English and publication date was 1990 or more recent. The search strategy used is displayed below.

Data analysis

Study selection

First, duplicates were removed. Then, the study selection was performed in two rounds. First, a selection based on title and abstract was performed, then selected articles were subject to a second screening based on full texts. Both rounds of selection were performed by two researchers independently and were each followed by a round of consensus. The eligibility criteria for the first selection based on title and abstract were the following.
Subsequently, when abstracts or titles adhered to the above screening criteria, full texts were independently screened for inclusion based on the following (additional) criteria.
Furthermore, articles from reference lists of reviews were identified. For these, we performed a shortened screening and selection procedure. Titles of these articles were screened based on the following criteria: a) > =1990; b) peer-reviewed article; c) randomized control trial or effect/effectiveness/efficacy study/treatment outcome; d) adolescents; e) delinquency/offenders/substance-abuse; f) mental health intervention (no pharmacotherapy). If this selection resulted in inclusion, the abstract was screened and a final decision on inclusion or exclusion was made. Included articles were added to the database of identified articles for further data synthesis.

Data extraction

Data extraction was performed in MS Access with predefined fields. From all selected studies, general information, such as the title of the study, the name of the author, journal, etc., were recorded, as well as information on the sample size, the studied population and type of intervention (systemic, other [i.e. individual, group intervention], both).
In addition to this general information, instrument-specific information was extracted. This information consisted of instrument names (e.g. Child Behavior Checklist [CBCL]) and covered domains (e.g. family functioning, adolescent behavior, etc.). This information was recorded in order to identify the instruments currently used in the field and their coverage of the different systems relevant for the evaluation of systemic family interventions (Fig. 1).

Synthesis and evaluation of results

As a next step, domain names of the instruments were extracted from the identified articles and linked to the systems relevant for the evaluation of systemic family interventions (Fig. 1): youth, family, peers, school, work, society and neighbors. Domain names were verified with available resources such as guidelines, websites of the developer and other articles using the same instrument. After verification, the domains were translated into the systems mentioned in Fig. 1. For this purpose, domains related to the adolescents themselves, such as ‘substance use and abuse’, ‘physical health’ or ‘mental health’ were linked to the system ‘youth’ whereas domains such as ‘family relations’ were recoded into the system ‘family’, domains like ‘peer relations’, ‘social skills’ or ‘leisure/recreation’ were labeled as ‘peer’ system, domains like ‘educational status’ were labeled ‘school’ and ‘delinquency’ as ‘society’. Table 1 provides an example of the process of recoding for the Problem Oriented Screening Instrument for Teenagers (POSIT). Next, all instruments were classified based on the number of systems (presented in Fig. 1) covered and ranked from highest to lowest. Those covering five or more systems were considered most relevant for our purpose as those covered the majority of effects of systemic family interventions in adolescents with substance use disorder or problems of delinquency.
Table 1
Example of recoding of domains into systems
Problem Oriented Screening Instrument for Teenagers (POSIT)
Domain
Corresponding system
Substance use and abuse
youth
Physical health
youth
Mental health
youth
Family relations
family
Peer relations
peers
Educational status
school
Vocational status
work
Social skills
peers
Leisure/recreation
peers,
Aggressive behavior/delinquency
society
In line with our aim to identify an instrument, which captures most of the systems relevant to the evaluation of systemic family interventions, those instruments covering more than five systems were evaluated in more detail. These were then appraised according to necessarily arbitrary characteristics of brevity, feasibility, practicability, accessibility, psychometric properties and acceptance in the field. These characteristics were set up as to identify one or more instruments suitable to attain societal preference-weights for an instrument by means of preference-elicitation techniques. Within preference-elicitation techniques, such as discrete choice experiments, the number of domains rarely exceeds ten [28, 29]. With higher numbers of domains, the decision task may become too complex and cognitively demanding for the respondent [28]. Hence, a suitable instrument should possess less than 10 domains. A second consideration was the practical use of the instrument itself in clients. An instrument, ideally suitable for self-completion, should put as little strain as possible on the respondent, without loss of important content. Hence, we set a limit to the maximum number of items of the instrument at 500 and a maximum completion time of 1 h, assuming that these would be reasonable amounts of items and time to ask from respondents. Another criterion was the accessibility of the instrument as to ascertain ease of use in future studies. Evaluation of this criterion included the price of use and availability of a (digital) version. Psychometric properties were considered to judge the suitability of the instrument for integration in health economic evaluations. Findings from existing publications on validity and reliability of the instruments were considered in this context. Finally, the frequency of use of the instrument was considered an indicator for the acceptance of the instrument in the clinical field. This was approximated by the number of times that an instrument was used in the studies identified in this review.

Results

Study selection

The systematic search resulted in 1060 articles. After duplicates were removed 1002 articles remained. Screening based on abstracts resulted in the exclusion of 880 articles. Full text assessment of the remaining 122 articles resulted in the exclusion of two articles not matching the definition of the intervention, 23 articles not matching the disease or symptoms of the target population, 13 not matching the requirements for the principle outcome of the studies, and 9 due to unavailability of a full text version. Hence 75 articles were included. Furthermore, 318 underlying articles from reviews were screened. From these, 166 articles remained after duplications with the first search results were removed. The screening of these articles in a first round by title and in a second round by title and abstract resulted in the exclusion of 161 articles and inclusion of five additional publications (Fig. 2).

Study results

A total of 80 articles were included in the synthesis. The aim was to identify clinical instruments in the field suitable for integration in a health-economic framework based on criteria of coverage of relevant systems, feasibility to perform preference-elicitation techniques, practicability of use, accessibility for future studies, psychometric properties and acceptance in the field. A summary of the identified reviews and clinical trials is provided in Tables 2 and 3 respectively. From the 80 selected articles we identified a total of 102 instruments, differing substantially in what these intended to measure and in whom. These instruments measured varying (combinations of) outcomes such as substance use, physical health, mental health, family relations, peer relations, school and work status and criminal history.
Table 2
List of identified reviews
ID
Authors
Year
Population
1
Armelius Bengt-Åke, Andreassen Tore Henning
2007
youth with antisocial behavior
2
Baldwin SA, Christian S, Berkeljon A, Shadish WR.
2011
adolescent delinquents and substance-abusers
3
Borduin CM.
1999
criminal and violent adolescents
4
Brown SA, D'Amico EJ.
2003
adolescent substance abusers
5
Cottrell D, Boston P.
2002
patients with conduct and attention deficit disorders, substance misuse, etc.
6
Curtis N, Ronan K, Borduin C M
2004
antisocial youths and youths with serious emotional disturbances
7
Deas D, Thomas SE.
2001
adolescents with substance use disorders
8
Deas D.
2007
adolescents with AOD disorders
9
Diamond G, Josephson A.
2005
adolescent substance use
10
Ferguson LM, Wormith JS.
2012
(adult and) young offenders
11
Henggeler SW, Sheidow AJ.
2012
conduct disorder and delinquency in adolescents
12
Henggeler SW, Sheidow AJ.
2003
conduct disorder and delinquency in adolescents
13
Hogue A, Liddle HA.
2009
adolescent substance abuse
14
Littell Julia H, Campbell Margo, Green Stacy, Toews Barbara
2005
(among others) delinquent youth
15
Randall J, Cunningham PB.
2003
violent substance-abusing and substance-dependent juvenile offenders
16
Tanner-Smith EE, Wilson SJ, Lipsey MW.
2013
adolescent substance use disorder
17
Tripodi SJ, Bender K, Litschge C, Vaughn MG.
2010
adolescent alcohol use
18
Waldron HB, Kaminer Y.
2004
adolescent substance use disorders
19
Waldron HB, Turner CW.
2008
adolescent substance abuse
20
Walker D F, McGovern S K, Poey E L, Otis K E
2004
adolescent sexual offenders
21
Woolfenden Susan, Williams Katrina J, Peat Jennifer
2001
adolescents with delinquency or conduct disorder
Table 3
Summary of identified clinical trials
ID
Authors
Year
Population
Age
Number
Effect measures
22
Arnold EM, Kirk RS, Roberts AC, Griffith DP, Meadows K, Julian J.
2003
incarcerated, sexually abused adolescent females
12–17
100
Multidimensional Adolescent Assessment Scale (MAAS)
23
Borduin CM, Mann BJ, Cone LT, Henggeler SW, Fucci BR, Blaske DM, Williams RA
1995
juvenile offenders
12–17
176
Symptom Checklist-90 (SCL-90-R);Revised Behavior Problem Checklist (RBPC); Family adaptability and cohesion evaluation scales-II (FACES-II); Nine-item unrevealed differences questionnaire-revised; Peer relations inventory (MPRI)
24
Borduin CM, Schaeffer CM, Heiblum N.
2009
juvenile sexual offenders
Mean 14
48
Global Severity Index (GSI) of the Brief Symptom Inventory (BSI); Revised Behavior Problem Checklist (RBPC); Family Adaptability and Cohesion Evaluation Scales II (FACES-II); 13-item Missouri Peer Relations Inventory (MPRI); Youth reports of the Self Report Delinquency Scale (SRD)
25
Brown SA, D'Amico EJ, McCarthy DM, Tapert SF.
2001
adolescents treated for alcohol and drug problems
14–18
166
Customary drinking and drug use record (CDDR); Hollingshead classification system; Health problems composite index
26
Burleson JA, Kaminer Y, Goldston DB, Haberek R
2005
Adolescent Alcohol Abuse or Alcohol Dependence Disorder
12–18 years; average 15.9
177
Suicidal Ideation Questionnaire (SIQ-JR); Teen Addiction Severity Index (T-ASI); Diagnostic interview scale for children (self-administered Voice-DISC)
27
Burleson JA, Kaminer Y.
2005
adolescents with substance use disorder
13–18
88
Situational confidence questionnaire (SCQ); Diagnostic interview schedule for children (DISC-C)
28
Cornelius JR, Douaihy A, Bukstein OG, Daley DC, Wood SD, Kelly TM, Salloum IM.
2011
adolescents with alcohol use disorder (AUD) and major depressive disorder (MDD)
15–20
75
Hamilton rating scale for depression (HAM-D-27); Beck Depression Index (BDI); Timeline follow-back method (TLFB)
29
D'Amico EJ, Ellickson PL, Wagner EF, Turrisi R, Fromme K, Ghosh-Dastidar B,Longshore DL, McCaffrey DF, Montgomery MJ, Schonlau M, Wright D.
2005
adolescents with alcohol and other drug problems (AOD)
13–19
289
Perceived stress scale; Revised way of coping checklist
30
Dembo R, Shemwell M, Guida J, Schmeidler J, Pacheco K, Seeberger W
1998
juvenile offenders
Mean 14
62
SCL-90-R
31
Dembo R, Wothke W, Livingston S, Schmeidler J
2002
juvenile offenders
11–18; mean 14.5
278
SCL-90-R
32
Dennis M, Godley S H, Diamond G, Tims F M, Babor T, Donaldson J, Liddle H, Titus J C, Kaminer Y, Webb C, Hamilton N, Funk R
2004
adolescent cannabis users
15–16
600
GAIN
33
Dennis M, Titus JC, Diamond G, Donaldson J, Godley SH, Tims FM, Webb C, KaminerY, Babor T, Roebuck MC, Godley MD, Hamilton N, Liddle H, Scott CK; C. Y. T.Steering Committee.
2002
cannabis dependence or abuse in adolescents
12–18
600
Drug Abuse Treatment Cost Analysis Program (DATCAP); Global Appraisal of Individual Needs (GAIN); Adolescent Reasons for Quitting (ARFQ); Family Environment Scale (FES); Friends, Family and Self (FFS); Adolescent Relapse Coping Questionnaire (ARCQ); SCID II personality questionnaire (SPQ); Dimensions of Temperament Revised (DOTS); Child Behavioral Checklist (CBCL)
34
Gil AG, Wagner EF, Tubman JG
2004
juvenile offenders
14–19
213
Timeline follow-back interview (TLFB);Problem recognition questionnaire (PRQ)
35
Glisson C, Schoenwald SK, Hemmelgarn A, Green P, Dukes D, Armstrong KS, Chapman JE
2010
delinquent youth
9–17
child behavior checklist (CBCL)
Child behavior checklist (CBCL)
36
Godley SH, Garner BR, Passetti LL, Funk RR, Dennis ML, Godley MD.
2010
adolescents with substance use disorder
12–18
320
GAIN Substance Problem Scale (SPS); DATCAP
37
Godley SH, Hedges K, Hunter B.
2011
adolescents with substance use
10–18
2141
GAIN
38
Hall JA, Smith DC, Easton SD, An H, Williams JK, Godley SH, Jang M
2008
youth in outpatient treatment for substance abuse
12–18
404
GAIN
39
Harold GT, Kerr DC, Van Ryzin M, Degarmo DS, Rhoades KA, Leve LD.
2013
adolescent girls in juvenile justice system
13–17
166
Brief symptom inventory (BSI)
40
Henderson CE, Dakof GA, Greenbaum PE, Liddle HA.
2010
adolescent drug abuse and delinquency
12–17
378
Personal Experience Inventory (PEI); Timeline follow-back method (TLFB); Diagnostic interview schedule for children, second edition (DISC-2); Family environment scale (FEI)
41
Henggeler SW, Halliday-Boykins CA, Cunningham PB, Randall J, Shapiro SB, Chapman JE.
2006
juvenile offenders meeting criteria for substance abuse or dependence
12–17
161
Form 90 based on TLFB; Self reported delinquency scale (SRD); Child behavior checklist (CBCL)
42
Henggeler SW, McCart MR, Cunningham PB, Chapman JE.
2012
youth substance abuse and criminal behavior
12–17
104
Form 90/TLFB; Self reported delinquency scale (SRD)
43
Henggeler SW, Melton GB, Brondino MJ, Scherer DG, Hanley JH
1997
violent and chronic juvenile offenders
11–17
155
Global severity index (GSI) of the BSI; Revised problem behavior checklist (RBPC); Self-report delinquency scale (SRD); Family adaptability and cohesion evaluation scales (FACES-III); Family assessment measure (FAM-III); Parent version monitoring index; Adolescent version monitoring index; 13-item Missouri peer relations inventory (MPRI); 14-item parent peer conformity inventory (PPCI)
44
Henggeler SW, Melton GB, Smith LA
1992
serious juvenile offenders
Mean 15,2
84
SRD (Self Report Delinquency Scale); FACES-III (The Family Adaptability and Cohesion Evaluation Scales); MPRI (Missouri Peer Relations Inventory); RBPC (Revised Behavior Problem Checklist); SCL-90 (Self Report Symptom Checklist); SCS-CBC
45
Henggeler SW, Pickrel SG, Brondino MJ.
1999
substance-abusing and -dependent delinquent adolescents
12–17
118
Personal experience inventory (PEI); Self-report delinquency scale (SRD)
46
Hogue A, Dauber S, Stambaugh LF, Cecero JJ, Liddle HA.
2006
substance-abusing adolescents
average 15.5
100
TLFB; CBCL; YSR
47
Hogue A, Henderson CE, Dauber S, Barajas PC, Fried A, Liddle HA.
2008
adolescent substance use and related behavior problems
13–17
136
Timeline follow-back (TLFB); Personal experience inventory (PEI); CBCL; YSR
48
Hunter SB, Ramchand R, Griffin BA, Suttorp MJ, McCaffrey D, Morral A.
2012
adolescent substance use
n/a
2751
GAIN; Emotional problem scale (EPS); Illegal activities scale (IAS); Past month substance problem scale (SPS-GAIN); Substance frequency scale (SFS-GAIN)
49
Kaminer Y, Burleson JA, Goldberger R
2002
adolescent substance-abusers
13–18
88
T-ASI; DISC-C; Structural clinical interview for the DSM (SCID-II); Revised dimensions of temperament survey (DOTES-R)
50
Kaminer Y, Burleson JA.
2008
adolescents with substance use disorder
13–18
88
T-ASI; DOTES-R
51
Keiley MK.
2007
incarcerated adolescents
13–18
73
Caregiver CBCL; Youth self-report (YSR); Coping inventory of stressful situations (CISS); Parental bonding instrument (PBI); Inventory of parent and peer attachment (IPPA)
52
Killeen TK, McRae-Clark AL, Waldrop AE, Upadhyaya H, Brady KT.
2012
adolescents with marijuana use disorders
12–18
31
Composite international diagnostic interview (CIDI); Teen Addiction Severity Index (T-ASI); Timeline Follow-back (TLFB); Marijuana craving questionnaire (MCQ-12); Barrett Impulsivity Scale (BIS-II-A)
53
Latimer WW, Winters KC, D'Zurilla T, Nichols M
2003
adolescent drug abusers
12–18
43
Diagnostic interview for children and adolescents (DICA-IV); Adolescent diagnostic interview revised (ADI-R)-multiaxal interview; Personal experience inventory (PEI); Family assessment measure (FAM); Social problem solving inventory (SPSI); Motivational learning questionnaire (MSLQ); Client personal history questionnaire (CPHHQ)
54
Letourneau EJ, Henggeler SW, Borduin CM, Schewe PA, McCart MR, Chapman JE, Saldana L
2009
juvenile sexual offenders
11–17
67
Adolescent sexual behavior inventory (ASBI); Self-report delinquency scale (SRD); Personal experience inventory (PEI); Child behavior checklist (CBCL)
55
Liddle HA, Dakof GA, Parker K, Diamond GS, Barrett K, Tejeda M
2001
clinically-referred marijuana- and alcohol-abusing adolescents
13–18
182
Adolescent grade point average (GPA); Acting out behaviors (AOB) scale; Global health pathology scale
56
Liddle HA, Rowe CL, Dakof GA, Henderson CE, Greenbaum PE
2009
young adolescent substance abusers
11–15
83
GAIN; TLFB; POSIT; SRD; National youth survey peer delinquency scale
57
Liddle HA, Rowe CL, Dakof GA, Ungaro RA, Henderson CE.
2004
adolescent substance abuse and behavioral problems
11–15
80
GAIN; Parent and adolescent interviews (CTRADA); Youth Self Report (YSR); Family Environment Scale (FES); National Youth Survey Peer Delinquency Scale; TLFB
58
Lott DC, Jencius S.
2009
adolescent substance abuse
12–18
264
(only urine specimen)
59
Marsden J, Stillwell G, Barlow H, Boys A, Taylor C, Hunt N, Farrell M
2006
young ecstasy and cocaine users
16–22
342
Maudsley addiction Profile (MAP); Severity of dependence scale (SDS)
60
Martin G, Copeland J.
2008
adolescent cannabis users
14–19
40
TLFB; Items from GAIN; Severity of dependence scale (SDS); Stage of change questionnaire
61
McCambridge J, Strang J.
2004
adolescent illegal drug use
16–20
200
Severity of Dependence Scale (SDS); Seven-point scale by Argyle; Drug Attitudes Scale (DAS); 12-item general health questionnaire (GHQ)
62
McGlynn AH, Hahn P, Hagan MP.
2012
juvenile offenders
12–18
518
HIT questionnaire
63
Moore SK, Marsch LA, Badger GJ, Solhkhah R, Hofstein Y.
2011
opoid-dependent adolescents
13–18
36
Youth Self Report (YSR)
64
Rigter H, Henderson CE, Pelc I, Tossmann P, Phan O, Hendriks V, Schaub M, RoweCL.
2012
adolescents with recent cannabis use disorder
13–18
450
Adolescent diagnostic interview-light (ADI-Light); TLFB
65
Robbins MS, Feaster DJ, Horigian VE, Rohrbaugh M, Shoham V, Bachrach K, Miller M,Burlew KA, Hodgkins C, Carrion I, Vandermark N, Schindler E, Werstlein R,Szapocznik J.
2011
adolescent drug abuse
Mean 15.5
480
TLFB; Diagnostic interview schedule for children (DISC); Parenting Practices Questionnaire; Family environment scale (FES)
66
Rohde P, Jorgensen JS, Seeley JR, Mace DE
2004
incarcerated youth
12–25
76
YSR; Life attitudes schedule-short form (LAS-SF); Self-esteem scale; 10-item UCLA loneliness scale; Subjective probability questionnaire; 4 items created and modeled after the social adjustment scale
67
Sawyer AM, Borduin CM
2011
serious and violent juvenile offenders
37,3
176
(no instruments, clinical records only)
68
Sealock MD, Gottfredson DC, Gallagher CA
1997
substance-abusing youthful offenders
n/a
460
Face valid alcohol (FVA) scale of SASSI; Face valid other drug (FVOD) scale of SASSI; Coping resources inventory (CRI); MEPS test
69
Sexton T, Turner CW
2010
adolescents adjudicated for crime and sentenced to probation
13–17
917
WAJCA-RA structured interview
70
Timmons-Mitchell J, Bender MB, Kishna MA, Mitchell CC
2006
juvenile justice involved youth
Mean 15.1
93
Child Adolescent Functional Assessment Scale (CAFAS)
71
Waldron HB, Kern-Jones S, Turner CW, Peterson TR, Ozechowski TJ.
2007
treatment resistant drug-abusing adolescents
14–20
72
BDI; State-anger subscale of the state-trait anger expression inventory (STAXI); State-anger anxiety inventory (STAI); TLFB; CBCL; YSR; Conflict and cohesion subscale of FES
72
Waldron HB, Slesnick N, Brody JL, Turner CW, Peterson TR.
2001
adolescent substance abuse
13–17
114
TLFB; POSIT; CBCL
73
Walker DD, Stephens R, Roffman R, Demarce J, Lozano B, Towe S, Berg B.
2011
adolescent cannabis users
14–19
311
Global Appraisal of Individual Needs (GAIN-I); Marijuana Problem Inventory (MPI) (adapted from RAPI)
74
Winters KC, Fahnhorst T, Botzet A, Lee S, Lalone B
2012
Alcohol and/or cannabis use disorder
12–18
315
PCS: 11-item self-report scale from the Personal Experience Inventory (PEI); Adolescent Diagnostic Interview (ADI); TLFB; Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES); Problem solving inventory; Child version of the Alabama Parenting Questionnaire (APQ); Treatment Services Review (TSR)
75
Winters KC, Leitten W.
2007
drug-abusing adolescents
14–17
79
Adolescent Diagnostic Interview (ADI) - substance use disorder module; TLFB; Personal consequences scale (PCS) from PEI; Treatment Services Review (TSR)
76
Chamberlain P, Leve LD, Degarmo DS
2007
Girls with serious and chronic delinquency
13–17
81
Elliott General Delinquency Scale
77
Liddle, HA, Dakof, GA, Turner, RM, Henderson, CE, Greenbaum, PE
2008
Youth with drug abuse/dependence
Mean 15
224
DISC; PEI; TLFB
78
Robbins MS, Szapocznik J, Dillon FR, Turner CW, Mitrani VB, Feaster DJ
2008
Substance-abusing or dependent adolescents
12–17, mean 15.6
190
DISC; TLFB; ADAD; Therapist Adherence Checklist
79
Smith DC, Hall JA, Williams JK, An H, Gotman N.
2006
Adolescent substance abuse
Mean 15.8
98
SFS and SPS scales of GAIN
80
Winters KC, Stinchfield RD, Opland E, Weller C, Latimer WW.
2000
Adolescent substance abuse
12–18
245
Drug consumption items of PEI

Instrument suitability for evaluation of systemic family interventions

Table 4 displays the instruments ranked according to the number of systems covered.
Table 4
Ranking of instruments according to the number of systems covered
Name instrument
# systems covered
Systems
youth
family
peers
school
work
society
neighbors
POSIT
6
 
CAFAS
6
 
WAJCA-RA
6
 
ADAD
6
 
T-ASI
6
 
CTRADA
5
 
 
ADI
5
 
 
GAIN
5
 
 
PEI
4
   
MAAS
4
   
FES
4
   
CPHHQ
3
  
  
FFS
3
    
SCQ
3
 
 
  
SRD
2
    
 
SCL-90-R
2
     
BSI
2
     
Hollinghead classification system
2
   
  
IPPA
2
 
    
CRI
2
     
MAP
2
 
    
Note. • = system covered by instrument
The majority, 81 instruments, covered just one system such as the youth or the family system. These one-dimensional instruments were often used in a multi-method (i.e. a combination of self-report, parent-report, court records, urine-analysis, etc.) assessment battery of instruments. Fourteen instruments covered two, three or four systems. We identified eight instruments, which covered five or more systems and which therefore were considered potentially suitable for comprehensive evaluation of systemic family interventions.
Detailed information on these eight instruments was searched and is highlighted below. It has to be noted that available information per instrument (e.g. number of items, example questions, domain names, most recent versions of the instrument, type of administration, etc.) strongly differed.
The Adolescent Drug Abuse Diagnosis (ADAD) [30] is a multidimensional instrument to evaluate adolescent substance use [31] administered in a structured interview. It covers nine problem areas: medical, school, employment, social relations, family and background relations, psychological, legal, alcohol use, and drug use [32]. Example questions are “How would you rate your overall physical health?”, “How many days in the past 30 have you been absent (from school)?” and “How many months did you work fulltime in the past six months?”. A patient’s treatment need is assessed by the interviewer per problem area based on a 10-point rating scale with scores 0–1 (no real problem), 2–3 (slight problem, treatment probably not necessary), 4–5 (moderate problem, some treatment indication), 6–7 (considerable problem, treatment necessary), and 8–9 (extreme problem, treatment absolutely necessary) [32]. The instrument consists of 150 items and is based on the Addiction Severity Index (ASI) [24]. There is also a European version of the instrument, the European Adolescent Assessment Dialogue (EuroADAD). Its aim is to “describe, communicate and compare young clients over borders of countries and institutions.” [33].
The Adolescent Diagnostic Interview (ADI) [34] originated in the 1980’s as a project “to address measurement gaps in the alcohol-drug field” [35]. It is a tool to measure substance use disorders in adolescents “…organized around DSM–III–R criteria for psychoactive substance use disorders.” [34]. In the literature a version based on DSM-IV criteria is also mentioned [36]. The instrument is administered in a structural interview setting. Substance use of the adolescent is assessed based on two main sections with each two subsections: clinical (sociodemographics, psychosocial stressors, substance use frequency and duration, alcohol symptoms, cannabis symptoms, other substance symptoms and level functioning) and appendix (orientation and memory screen) [34]. Example items are “Which drugs have you used five or more times in your life?”, “How many times do you think that you have used (this drug/each drug) in the past 6 months?”, “Have you ever continuously felt like crying for several days in a row?” [36]. A computer-based version is available for self-assessment [34].
The Child Adolescent Functional Assessment Scale (CAFAS) “…assesses the degree of impairment in functioning in children and adolescents secondary to emotional, behavioral, or substance use problems” [37]. The instrument originally included seven scales, of which five evaluated the functioning of the youth and two scales assessed the environment of the youth [37]. The five youth scales were role performance, thinking, behavior towards self and others, moods/emotions, and substance use [37]. The two environment scales were basic needs and family/social support. The scales subsequently have been changed and expanded to 8 youth and 2 caregiver scales: school, home, community, behavior towards others, moods, self-harm, substance use, and thinking (youth) and material needs, and social support (caregiver) [38]. The different subscales include items of four severity levels (i.e. severe, moderate, mild, and minimal or no impairment) [37]. The assessor determines the level of problems of the patient per subscale. He first considers the items of the most severe level, checks whether these items apply and if not progresses towards the lesser symptom levels until an item of the current severity level applies to the patient [37]. Then scores of 30, 20, 10 and 0 are applied to severity levels severe, moderate, mild and minimal respectively such that an overall severity rating is generated. Overall ratings range from 0 to 240 with higher scores indicating higher severity [30].
The Global Appraisal of Individual Needs (GAIN) questionnaire [39] is a collection of related instruments that are gathered under the umbrella of GAIN using an identical format. The most recent version of the questionnaire has been adapted for use in adults as well as adolescents. The GAIN is an assessment measure, which can be used in several settings and populations such as inpatient, outpatient short- or long-term treatment evaluation, legal programs or school-based programs [40]. It assesses eight domains: background, substance use, physical health, risk behaviors, mental health, environment, legal, and vocational. Example items of the GAIN are “During the past 90 days, on how many days were you in foster care?”, “When was the last time, if ever, you used...any kind of alcohol?”, and “What was the most (drinks/joints/etc.) you had in one day?” [41].
The Problem Oriented Screening Instrument for Teenagers (POSIT) is a screening instrument for adolescents with substance use disorder, which was designed as a component of the Adolescent Assessment/Referral System (AARS) [42]. It “is designed to flag those functional areas, if any, where a problem MAY exist that requires further assessment and perhaps treatment.” [42]. The instrument addresses ten functional domains: substance use/abuse, physical health status, mental health status, family relations, peer relations, educational status, vocational status, social skills, leisure and recreation, and aggressive behavior and delinquency. The POSIT includes 139 items, which can be answered with yes or no [42]. Per domain, items can be grouped into three categories: general purpose items, general purpose age-related items, and red flag items [42]. Each affirmative response to a general purpose item counts as one point towards the total functional domain score [42]. The same holds for general purpose age-related items, but these are only relevant for specific age groups of respondents (below or above 16 years) [42]. Red flag items indicate the need for treatment once one of these items is answered positively [42]. Example items of the POSIT are “Do you get into trouble because you use drugs or alcohol at school?”, “Do your parents or guardians argue a lot?”, and “Have you ever been told you are hyperactive?” [42].
The Teen Addiction Severity Index (T-ASI) [43] is the adolescent version of the ASI [24]. The instrument assesses seven dimensions of functioning (i.e. alcohol and drug use, school status, employment-support status, family relationships, legal status, peer-social relationships, and psychiatric status) [43]. The T-ASI is intended for use in adolescents with substance use disorder aged between 12 and 19 years [43]. Example items of the T-ASI are “What chemicals have you used in the past month?”, “School days spent in detention or any other measures taken for disciplinary reasons last month. (Principal's or school counselor's office.)”, and “How long was your longest period of employment during the past year?” [44]. Responses are rated on a 5-point scale [43]. A revised version of the T-ASI, the T-ASI-2 has been developed in 2008. This concerns a version of the instrument, which is self-administered via computer or telephone and contains additional domains [45].
The WAJCA-RA structured interview is a risk assessment tool for juvenile offenders developed by the Washington State Institute for Public Policy in collaboration with the juvenile courts [46]. It was designed to identify risk and protective factors in the following domains: criminal history, school, use of free time, employment, relationships, family, alcohol and drugs, mental health, attitudes, social skills, progress on community supervision, progress while confined [46]. Example items of the WAJCA-RA are “Violence/anger: Reports of displaying a weapon, fighting, threatening people, violent outbursts, violent temper, fire starting, animal cruelty, destructiveness, volatility, intense reactions.”, “Runaways or times kicked out of home”, and “Number of weeks of longest period of employment” [46].
The Parent and adolescent interview CTRADA that was used by Liddle et al. [47] was not considered a common instrument but institution-specific interview as no references could be retrieved from neither literature nor the Internet. The instrument therefore could not be further considered or assessed.

Instrument suitability for use in CUA

Hence seven instruments remained for further consideration. The frequency of use of each of these instruments in the identified studies is presented in Table 5. Furthermore, Table 6 illustrates an evaluation of the instruments for suitability for use in CUA and use of preference elicitation techniques. When our feasibility characteristics were applied to the seven instruments, three instruments (POSIT, WAJCA, ADI) were excluded due to the number of domains exceeding ten, and one instrument (GAIN) was excluded due to reasons of practicability (i.e. number of items exceeding the maximum of 500 and completing time exceeding 1 h). It was noted that a short version of the GAIN (Global Appraisal of Individual Needs Short Screener, GAIN-SS) is available as well [48]. However, based on its goals of screening, use for clinical staff with limited experience or periodic measurement [48], this instrument is considered too restricted for the purpose of this study. The remaining three instruments (CAFAS, T-ASI and Euro-ADAD) were considered candidates for use in CUA. One instrument (CAFAS) was considered slightly less suitable due to reasons of accessibility (i.e. concerning a paid instrument as opposed to freely available online versions of other instruments). For the remaining two instruments (T-ASI and the Euro-ADAD) only limited information on psychometric properties could be obtained. It needs noting that the T-ASI and Euro-ADAD are related as they are both based on the ASI adult instrument [33, 43]. Psychometric properties of this ‘predecessor’ have been judged satisfactory [24, 4952]. To our knowledge Euro-ADAD is more frequently used in Europe, whereas T-ASI is more commonly used in the United States.
Table 5
Frequency of instrument use
Instrument name
# of papers which used this measure
Global Appraisal of Individual Needs (GAIN)
13
Teen Addiction Severity Index (T-ASI)
4
Adolescent Diagnostic Interview (ADI)
4
Problem Oriented Screening Instrument for Teenagers (POSIT)
2
Child Adolescent Functional Assessment Scale (CAFAS)
1
Washington Association of Juvenile Court 6Administrators - Risk Assessment (WAJCA-RA)
1
Adolescent Drug Abuse Diagnosis (Euro-ADAD)
1
Table 6
Evaluation of multidimensional instruments covering five or more systems
Selection criterion
T-ASI
Euro-ADAD
CAFAS
GAIN
POSIT
WAJCA-RA
ADI
1) feasibility discrete choice experiment:
# domains < 10
7
8
8 (+2 optional caregiver domains)
8
10
12
12
2) practicability of assessment in clients:
- # items < 500
- tta < 60 min.
154
150
165
1606
   
30-45
45-55
10
60-120
   
3) accessibility:
price and availability of digital version
Digital version available free of charge
Digital version available free of charge
Available via paid online system (price $78-$400)
    
4) psychometric properties [validity (content validity, construct validity, sensitivity to change); reliability (test/retest reliability, internal consistency)]
Kaminer, 1991:
“…interrater reliability is very good; indeed, it equals or surpasses that found for most interview instruments…” “Although further refinement needs to be made with respect to the Family Relationship ScaIe, the other individual scale ratings and the overall rating agreement is quite high, underscoring the reliability of the T-ASI.” (N=25)
Czobor, 2011:
Good test-retest reliability (Pearson’s r
>= 0.8 for most individual domains) and internal consistency (“Based on Cronbach’s coefficient alpha the internal consistency/reliability of the instrument was 0.50… when we applied an extension of the internal consistency/ reliability measure for multidimensional case, we found that the internal consistency/reliability was satisfactory.”); good criterion, convergent and discriminant construct validity. (N=632)
     
 
Kaminer, 1993:
“…1) T-ASI discriminated between psychoactive substance use disorders (PSUD) and non-PSUD in adolescents within a group of psychiatric inpatients; 2) T-ASI substance use, psychiatric status, family function, and school status scores were related to external criteria; 3) there was specificity in these relations with external criteria…support for the valid psychometric properties of the T-ASI….All results should be interpreted in the context of the small sample size (N=25).”
     
5) frequency of use in the field:
- number of times used in studies
4
1
     
Two psychometric studies with small sample sizes were identified for the T-ASI [43, 53] and one study [33] with a larger sample size was identified for the Euro-ADAD. Frequency of use was slightly favorable for the T-ASI compared to the Euro-ADAD as the instrument was used four times in the studies identified in this systematic review, whereas the Euro-ADAD was used in no more than one study. These differences were not considered sufficient to justify favoring either of the instruments over the other. Hence, the T-ASI and Euro-ADAD were considered to have equal potential suitability for the comprehensive evaluation of systemic family interventions in a health economic framework.

Discussion and conclusions

The objective of this systematic literature review was to identify existing instruments in the field of adolescent delinquency and substance use, which cover the relevant domains of systemic family interventions. The instruments were appraised based on characteristics relevant for use in economic evaluations such as brevity, accessibility, psychometric properties etc. Euro-ADAD and T-ASI showed favorable characteristics in relation to the criteria for a comprehensive outcome measure, covering multiple relevant systems and being suitable for obtaining preference weights. Both instruments lack preference weights for the outcomes, at present. Attaining these (as a potential next step) would facilitate calculating ‘utility scores’ as common in economic evaluations. Furthermore, the results of the current study may inform future efforts towards standardized and comprehensive core outcome sets as defined by the COMET initiative [54]. The study may be seen as a preparatory step towards a full COMET effort to standardizing the QALY approach to include broader effects.
Some limitations of this study must be noted. First, given our focus on published research up to 2013, we may have missed out on very recent developments in this field. In the Netherlands, for instance, a new, comprehensive instrument for measuring substance abuse in adolescents is being developed, called the MATE-Y [55], which includes nine modules each containing several domains. Yet, up to today there have not yet been publications on the MATE in the field of youth/adolescents. But similar developments may be ongoing elsewhere. Second, we have not investigated the possibility of constructing a new measure by combining different measures into one composite measure. Though this may be a limitation of this paper, we considered it a necessary first step to identify the instruments currently available in the field for direct use. This may also help to highlight the relevant domains to include in a newly developed instrument. With our approach, we were able to identify two instruments as most promising candidates to use in comprehensive evaluations of systemic family interventions. Neither instrument is currently considered ‘gold standard’ in practice. Furthermore, as common for systematic reviews, the results from the current study are based on a limited selection of databases within a limited timeframe. Yet the number of screened and identified articles was extensive and we assume that the consultation of an even larger number of databases would not have yielded significant differences in results. Also, the characteristics for further selection of the instruments were necessarily arbitrary and guided by our goal of selecting one or more instruments suitable to be used to attain societal preference weights and be used in economic evaluations in the long term. We realize that the suitability criterion of a maximum of 500 questions/1 h of completion time may be rather high when considering the busy clinical practice and ongoing evaluation of patient progress. Furthermore, had we considered different or more broad characteristics, additional instruments might have been found suitable. For example, one could think of shortening existing longer instruments first and then proceeding towards steps of attaining societal preference weights. In the light of limited time, this was not considered feasible in the current study.
Notwithstanding these limitations, our review revealed two promising, currently used instruments, which may be made suitable for inclusion in economic evaluations of systemic family interventions: the Euro-ADAD and T-ASI. To make these instruments suitable for health economic evaluations, first of all, more detailed investigation is necessary of their validity, feasibility and comprehensiveness. Current information on this is scarce, yet needed. Moreover, using these instruments in health economic evaluations will require important next steps. In particular, preference weights would need to be derived for the different states described by the instrument, like those available for health-related utility measures such as the EQ-5D. This is possible through preference elicitation techniques, such as discrete choice experiments or time-trade-off techniques, ultimately leading to ‘utility scores’, which can be attached to the different ‘states’ described by the instrument.
Intriguing questions in this context relate to who should indicate the state a person is in and who should provide the values for the different possible states (i.e., whose preferences count). In line with many guidelines for health-economic evaluations [11, 56], and in line with the broad aim of systemic family interventions, one could ask ‘patients’ to provide self-reports based on one of the identified multidimensional instruments. The value attached to this state could then be based on preferences obtained in the general population. This would provide ‘societal weights’ for the broad outcomes of systemic family interventions. These societal weights could thus be attached to the state a person indicates him- or herself to be in on the multidimensional instrument, thus leading to an overall utility score. Given the broad range of outcomes, including effects incurred by others than the patient or even his family (e.g., a safe neighborhood), the score thus relates to a preference ordering over states that include the effects on more than the patient alone. This may be an additional reason for opting for general public preferences. However, whether the general public is the appropriate source (rather than e.g. decision makers or health care professionals) must be further assessed and discussed, as well as their ability to appropriately weight such diverse outcomes. The more fundamental question is whether these scores would count as ‘utilities’ or rather as multi-criteria decision weights.
Other relevant issues in developing a multidimensional utility measure of systemic family interventions may be the diversity and hierarchy of treatment effects. As mentioned earlier, a comprehensive measure would include health as well as non-health effects and would also include both the effects on the patient himself and society as a whole. Obviously, these different effects may be interrelated. Moreover, some observable effects may be considered to be intermediate effects, whereas others may be final outcomes. Related to this point, there may be short-term and long-term effects, which can be important. Hence, in the construction of such a preference-based measure, good care needs to be taken of the possible interaction of the effects.
One may argue that an alternative route to finding an appropriate outcome measure could be to use existing measures in the field of economic evaluation, most notably QALY measures. To our knowledge, so far there have been only a few studies on the validity of preference-weighted health-related quality of life instruments in an adult population of substance abusers [57, 58]. There have been two studies on the degree to which common preference-weighted measures of quality of life (e.g. QWB-SA, SF-12) correlate with substance use severity [58, 59]. Whereas the first study provides evidence for insufficient coverage of all disease dimensions in substance use disorder [58], the second study does suggest moderate to good correlation between quality of life measures and substance use severity measures [59]. In order to verify these results and determine whether the proposed instruments add value in the field of delinquency and substance abuse in adolescents, further research on the suitability and potential of the quality adjusted life year (QALY) measure in this population is recommended.
Keeping these alternatives in mind, further research on the instruments highlighted in the current paper, specifically on the attachment of societal preference weights could bring evaluation of mental health interventions for delinquent and substance abusing adolescents closer to the standard methodology in health economic evaluations of curative medical interventions. Both identified instruments appear suitable and broad enough to capture the effects of family interventions in substance abusing and delinquent adolescents in such CUA. Adding societal preference weights to one of these instruments will create an instrument, which combines the advantage of the specificity of a disorder-specific instrument with compliance with common methodology of health economic evaluations and captures the broad effects relevant to mental health interventions. CUAs of these interventions can then be performed based on a broad and specific measure that includes several systems/dimensions and at the same time acknowledges the relative value that society attaches to improvements in these diverse systems. Though performing CUAs in the field of substance abuse and delinquency in adolescents remains a challenging task, this paper attempted to contribute to confronting one of the major issues in that context: finding a suitable outcome measure.

Acknowledgements

The authors would like to thank Maartje Goorden for her assistance in screening the publications.

Availability of data and material

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Funding

The study was conducted with a grant from the Netherlands organization for health research and development (ZonMw), The Hague. The funding organization had no role in the in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Not applicable.
Not applicable.

Competing interests

Clazien Bouwmans (CB), Werner Brouwer (WB) and Leona Hakkaart (LH) declare to have no competing interests. Saskia Schawo (SS), Evelien van der Schee (ES) and Vincent Hendriks (VH) are employees of Parnassia Groep, a Dutch mental health institution, which among others offers systemic interventions to its clients.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Cottrell D, Boston P. Practitioner review: The effectiveness of systemic family therapy for children and adolescents. J Child Psychol Psychiatry. 2002;43(5):573–86.PubMedCrossRef Cottrell D, Boston P. Practitioner review: The effectiveness of systemic family therapy for children and adolescents. J Child Psychol Psychiatry. 2002;43(5):573–86.PubMedCrossRef
2.
Zurück zum Zitat Randall J, Cunningham PB. Multisystemic therapy: a treatment for violent substance-abusing and substance-dependent juvenile offenders. Addict Behav. 2003;28(9):1731–9.PubMedCrossRef Randall J, Cunningham PB. Multisystemic therapy: a treatment for violent substance-abusing and substance-dependent juvenile offenders. Addict Behav. 2003;28(9):1731–9.PubMedCrossRef
3.
Zurück zum Zitat Brysbaert M. Psychologie. Gent: Academia Press; 2009. Brysbaert M. Psychologie. Gent: Academia Press; 2009.
4.
Zurück zum Zitat Hendriks V, van der Schee E, Blanken P. Treatment of adolescents with a cannabis use disorder: main findings of a randomized controlled trial comparing multidimensional family therapy and cognitive behavioral therapy in The Netherlands. Drug Alcohol Depend. 2011;119:64–71. Hendriks V, van der Schee E, Blanken P. Treatment of adolescents with a cannabis use disorder: main findings of a randomized controlled trial comparing multidimensional family therapy and cognitive behavioral therapy in The Netherlands. Drug Alcohol Depend. 2011;119:64–71.
5.
Zurück zum Zitat Henggeler SW, Sheidow AJ. Empirically supported family-based treatments for conduct disorder and delinquency in adolescents. J Marital Fam Ther. 2002;38(1):30–58.CrossRef Henggeler SW, Sheidow AJ. Empirically supported family-based treatments for conduct disorder and delinquency in adolescents. J Marital Fam Ther. 2002;38(1):30–58.CrossRef
6.
Zurück zum Zitat French MT, Zavala SK, McCollister KE, Waldron HB, Turner CW, Ozechowski TJ. Cost-effectiveness analysis of four interventions for adolescents with a substance use disorder. J Subst Abus Treat. 2008;34(3):272–81.CrossRef French MT, Zavala SK, McCollister KE, Waldron HB, Turner CW, Ozechowski TJ. Cost-effectiveness analysis of four interventions for adolescents with a substance use disorder. J Subst Abus Treat. 2008;34(3):272–81.CrossRef
7.
Zurück zum Zitat Borduin CM, Mann BJ, Cone LT, Henggeler SW, Fucci BR, Blaske DM, et al. Multisystemic treatment of serious juvenile offenders: long-term prevention of criminality and violence. J Consult Clin Psychol. 1995;63(4):569–78.PubMedCrossRef Borduin CM, Mann BJ, Cone LT, Henggeler SW, Fucci BR, Blaske DM, et al. Multisystemic treatment of serious juvenile offenders: long-term prevention of criminality and violence. J Consult Clin Psychol. 1995;63(4):569–78.PubMedCrossRef
8.
Zurück zum Zitat Henggeler SW, Clingempeel WG, Brondino MJ, Pickrel SG. Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry. 2002;41(7):868–74.PubMedCrossRef Henggeler SW, Clingempeel WG, Brondino MJ, Pickrel SG. Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry. 2002;41(7):868–74.PubMedCrossRef
9.
Zurück zum Zitat Liddle HA, Rowe CL, Dakof GA, Henderson CE, Greenbaum PE. Multidimensional family therapy for young adolescent substance abuse: twelve-month outcomes of a randomized controlled trial. J Consult Clin Psychol. 2009;77(1):12–25.PubMedCrossRef Liddle HA, Rowe CL, Dakof GA, Henderson CE, Greenbaum PE. Multidimensional family therapy for young adolescent substance abuse: twelve-month outcomes of a randomized controlled trial. J Consult Clin Psychol. 2009;77(1):12–25.PubMedCrossRef
10.
Zurück zum Zitat Sexton T, Turner CW. The effectiveness of functional family therapy for youth with behavioral problems in a community practice setting. J Fam Psychol. 2010;24(3):339–48.PubMedPubMedCentralCrossRef Sexton T, Turner CW. The effectiveness of functional family therapy for youth with behavioral problems in a community practice setting. J Fam Psychol. 2010;24(3):339–48.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat College voor Zorgverzekeringen. Dutch guidelines for pharmacoeconomic research. revised ed. Diemen: College voor Zorgverzekeringen; 2006. College voor Zorgverzekeringen. Dutch guidelines for pharmacoeconomic research. revised ed. Diemen: College voor Zorgverzekeringen; 2006.
12.
Zurück zum Zitat National Institute for Health and Care Excellence: Guide to the methods of technology appraisal; 2013. National Institute for Health and Care Excellence: Guide to the methods of technology appraisal; 2013.
13.
Zurück zum Zitat Goorden M, Van Der Schee E, Hendriks VM, Hakkaart-van Roijen L. Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis use disorder: Data from a randomized controlled trial. Drug Alcohol Depend. 2016, May 1;162:154–61.PubMedCrossRef Goorden M, Van Der Schee E, Hendriks VM, Hakkaart-van Roijen L. Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis use disorder: Data from a randomized controlled trial. Drug Alcohol Depend. 2016, May 1;162:154–61.PubMedCrossRef
14.
Zurück zum Zitat Brazier J. Is the EQ–5D fit for purpose in mental health? Br J Psychiatry. 2010;197(5):348–9.PubMedCrossRef Brazier J. Is the EQ–5D fit for purpose in mental health? Br J Psychiatry. 2010;197(5):348–9.PubMedCrossRef
15.
Zurück zum Zitat Knapp M, Mangalore R. The trouble with QALYs. Epidemiol Psychiatr Soc. 2007;16(4):289–93.CrossRef Knapp M, Mangalore R. The trouble with QALYs. Epidemiol Psychiatr Soc. 2007;16(4):289–93.CrossRef
16.
17.
Zurück zum Zitat Al-Janabi H, Flynn TN, Coast J. Estimation of a preference-based carer experience scale. Med Decis Mak. 2011;31(3):458–68.CrossRef Al-Janabi H, Flynn TN, Coast J. Estimation of a preference-based carer experience scale. Med Decis Mak. 2011;31(3):458–68.CrossRef
18.
Zurück zum Zitat Al-Janabi H, Coast J, Flynn TN. What do people value when they provide unpaid care for an older person? A meta-ethnography with interview follow-up. Soc Sci Med. 2008;67(1):111–21.PubMedCrossRef Al-Janabi H, Coast J, Flynn TN. What do people value when they provide unpaid care for an older person? A meta-ethnography with interview follow-up. Soc Sci Med. 2008;67(1):111–21.PubMedCrossRef
19.
Zurück zum Zitat Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093–103.PubMedCrossRef Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093–103.PubMedCrossRef
20.
Zurück zum Zitat Goorden M, Schawo SJ, Bouwmans-Frijters CA, van der Schee E, Hendriks VM, Hakkaart-van RL. The cost-effectiveness of family/family-based therapy for treatment of externalizing disorders, substance use disorders and delinquency: a systematic review. BMC Psychiatry. 2016;16(1):237.PubMedPubMedCentralCrossRef Goorden M, Schawo SJ, Bouwmans-Frijters CA, van der Schee E, Hendriks VM, Hakkaart-van RL. The cost-effectiveness of family/family-based therapy for treatment of externalizing disorders, substance use disorders and delinquency: a systematic review. BMC Psychiatry. 2016;16(1):237.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Jofre-Bonet M, Sindelar JL. Creating an aggregate outcome index: cost-effectiveness analysis of substance abuse treatment. J Behav Health Serv Res. 2004;31(3):229–41.PubMedCrossRef Jofre-Bonet M, Sindelar JL. Creating an aggregate outcome index: cost-effectiveness analysis of substance abuse treatment. J Behav Health Serv Res. 2004;31(3):229–41.PubMedCrossRef
22.
Zurück zum Zitat Deas D, Thomas SE. An overview of controlled studies of adolescent substance abuse treatment. Am J Addict. 2001;10(2):178–89.PubMedCrossRef Deas D, Thomas SE. An overview of controlled studies of adolescent substance abuse treatment. Am J Addict. 2001;10(2):178–89.PubMedCrossRef
23.
Zurück zum Zitat Hogue A, Liddle HA. Family-based treatment for adolescent substance abuse: controlled trials and new horizons in services research. J Fam Ther. 2009;31(2):126–54.PubMedPubMedCentralCrossRef Hogue A, Liddle HA. Family-based treatment for adolescent substance abuse: controlled trials and new horizons in services research. J Fam Ther. 2009;31(2):126–54.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26–33.PubMedCrossRef McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26–33.PubMedCrossRef
25.
Zurück zum Zitat Bronfenbrenner U. Contexts of child rearing: problems and prospects. Am Psychol. 1979;34(10):844.CrossRef Bronfenbrenner U. Contexts of child rearing: problems and prospects. Am Psychol. 1979;34(10):844.CrossRef
26.
Zurück zum Zitat Hinton WJ, Sheperis C, Sims P. Family-based approaches to juvenile delinquency: a review of the literature. Fam J Alex Va. 2003;11(2):167–73. Hinton WJ, Sheperis C, Sims P. Family-based approaches to juvenile delinquency: a review of the literature. Fam J Alex Va. 2003;11(2):167–73.
27.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.PubMedPubMedCentralCrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55–64.PubMed Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55–64.PubMed
29.
Zurück zum Zitat Witt J, Scott A, Osborne R. Designing choice experiments with many attributes. An application to setting priorities for orthopaedic waiting lists. J Health Econ. 2009;18:681–96.CrossRef Witt J, Scott A, Osborne R. Designing choice experiments with many attributes. An application to setting priorities for orthopaedic waiting lists. J Health Econ. 2009;18:681–96.CrossRef
30.
Zurück zum Zitat Friedman AS, Utada A. A method for diagnosing and planning the treatment of adolescent drug abusers (the Adolescent Drug Abuse Diagnosis [ADAD] instrument). J Drug Educ. 1989;19(4):285–312.PubMedCrossRef Friedman AS, Utada A. A method for diagnosing and planning the treatment of adolescent drug abusers (the Adolescent Drug Abuse Diagnosis [ADAD] instrument). J Drug Educ. 1989;19(4):285–312.PubMedCrossRef
31.
Zurück zum Zitat Chinet L, Plancherel B, Bolognini M, Holzer L, Halfon O. Adolescent substance-use assessment: methodological issues in the use of the Adolescent Drug Abuse Diagnosis (ADAD). Subst Use Misuse. 2007;42(10):1505–25.PubMedCrossRef Chinet L, Plancherel B, Bolognini M, Holzer L, Halfon O. Adolescent substance-use assessment: methodological issues in the use of the Adolescent Drug Abuse Diagnosis (ADAD). Subst Use Misuse. 2007;42(10):1505–25.PubMedCrossRef
33.
Zurück zum Zitat Czobor P, Bacskai E, Oberg D, Haack MJ, Gerevich J. The European Adolescent Assessment Dialogue (EuroADAD): a psychometric evaluation. Eur Addict Res. 2011;17(6):302–15.PubMedCrossRef Czobor P, Bacskai E, Oberg D, Haack MJ, Gerevich J. The European Adolescent Assessment Dialogue (EuroADAD): a psychometric evaluation. Eur Addict Res. 2011;17(6):302–15.PubMedCrossRef
34.
Zurück zum Zitat Winters KC, Stinchfield RD, Fulkerson J, Henly GA. Measuring alcohol and cannabis use disorders in an adolescent clinical sample. Psychol Addict Behav. 1993;7(3):185–96.CrossRef Winters KC, Stinchfield RD, Fulkerson J, Henly GA. Measuring alcohol and cannabis use disorders in an adolescent clinical sample. Psychol Addict Behav. 1993;7(3):185–96.CrossRef
35.
Zurück zum Zitat Winters KC, Stinchfield RD, Henly GA. Further validation of new scales measuring adolescent alcohol and other drug abuse. J Stud Alcohol. 1993;54(5):534–41.PubMedCrossRef Winters KC, Stinchfield RD, Henly GA. Further validation of new scales measuring adolescent alcohol and other drug abuse. J Stud Alcohol. 1993;54(5):534–41.PubMedCrossRef
37.
Zurück zum Zitat Hodges K, Wong MM. Psychometric characteristics of a multidimensional measure to assess impairment: the child and adolescent functional assessment scale. J Child Fam Stud. 1996;5(4):445–67.CrossRef Hodges K, Wong MM. Psychometric characteristics of a multidimensional measure to assess impairment: the child and adolescent functional assessment scale. J Child Fam Stud. 1996;5(4):445–67.CrossRef
39.
Zurück zum Zitat Dennis M, Godley SH, Diamond G, Tims FM, Babor T, Donaldson J, et al. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J Subst Abus Treat. 2004;27(3):197–213.CrossRef Dennis M, Godley SH, Diamond G, Tims FM, Babor T, Donaldson J, et al. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J Subst Abus Treat. 2004;27(3):197–213.CrossRef
42.
Zurück zum Zitat Rahdert E R: The Adolescent Assessment/Referral System Manual 1991. Rahdert E R: The Adolescent Assessment/Referral System Manual 1991.
43.
Zurück zum Zitat Kaminer Y, Bukstein O, Tarter RE. The Teen-Addiction Severity Index: rationale and reliability. Int J Addict. 1991;26(2):219–26.PubMedCrossRef Kaminer Y, Bukstein O, Tarter RE. The Teen-Addiction Severity Index: rationale and reliability. Int J Addict. 1991;26(2):219–26.PubMedCrossRef
45.
Zurück zum Zitat Brodey BB, McMullin D, Kaminer Y, Winters KC, Mosshart E, Rosen CS, et al. Psychometric characteristics of the Teen Addiction Severity Index-Two (T-ASI-2). Substance abuse. 2008;29(2):19–32.PubMedCrossRef Brodey BB, McMullin D, Kaminer Y, Winters KC, Mosshart E, Rosen CS, et al. Psychometric characteristics of the Teen Addiction Severity Index-Two (T-ASI-2). Substance abuse. 2008;29(2):19–32.PubMedCrossRef
47.
Zurück zum Zitat Liddle HA, Rowe CL, Dakof GA, Ungaro RA, Henderson CE. Early intervention for adolescent substance abuse: pretreatment to posttreatment outcomes of a randomized clinical trial comparing multidimensional family therapy and peer group treatment. J Psychoactive Drugs. 2004;36(1):49–63.PubMedCrossRef Liddle HA, Rowe CL, Dakof GA, Ungaro RA, Henderson CE. Early intervention for adolescent substance abuse: pretreatment to posttreatment outcomes of a randomized clinical trial comparing multidimensional family therapy and peer group treatment. J Psychoactive Drugs. 2004;36(1):49–63.PubMedCrossRef
49.
Zurück zum Zitat Hendriks VM, Kaplan CD, van Limbeek J, Geerlings P. The Addiction Severity Index: reliability and validity in a Dutch addict population. J Subst Abus Treat. 1989;6(2):133–41.CrossRef Hendriks VM, Kaplan CD, van Limbeek J, Geerlings P. The Addiction Severity Index: reliability and validity in a Dutch addict population. J Subst Abus Treat. 1989;6(2):133–41.CrossRef
50.
Zurück zum Zitat Leonhard C, Mulvey K, Gastfriend DR, Shwartz M. The Addiction Severity Index: a field study of internal consistency and validity. J Subst Abus Treat. 2000;18(2):129–35.CrossRef Leonhard C, Mulvey K, Gastfriend DR, Shwartz M. The Addiction Severity Index: a field study of internal consistency and validity. J Subst Abus Treat. 2000;18(2):129–35.CrossRef
51.
Zurück zum Zitat McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, et al. New data from the Addiction Severity Index. Reliability and validity in three centers. J Nerv Ment Dis. 1985;173(7):412–23.PubMedCrossRef McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, et al. New data from the Addiction Severity Index. Reliability and validity in three centers. J Nerv Ment Dis. 1985;173(7):412–23.PubMedCrossRef
52.
Zurück zum Zitat Zanis DA, McLellan AT, Cnaan RA, Randall M. Reliability and validity of the Addiction Severity Index with a homeless sample. J Subst Abus Treat. 1994;11(6):541–8.CrossRef Zanis DA, McLellan AT, Cnaan RA, Randall M. Reliability and validity of the Addiction Severity Index with a homeless sample. J Subst Abus Treat. 1994;11(6):541–8.CrossRef
53.
Zurück zum Zitat Kaminer Y, Wagner E, Plummer B, Seifer R. Validation of the Teen Addiction Severity Index (T-ASI). American Academy of Psychiatrists in Alcoholism and Addictions. 1993;2(3):250–4. Kaminer Y, Wagner E, Plummer B, Seifer R. Validation of the Teen Addiction Severity Index (T-ASI). American Academy of Psychiatrists in Alcoholism and Addictions. 1993;2(3):250–4.
55.
Zurück zum Zitat Schippers G, Broekman T. MATE-Y 2.1a - handleiding en protocol voor de MATE-jeugd. Beta Boeken: Nijmegen; 2013. Schippers G, Broekman T. MATE-Y 2.1a - handleiding en protocol voor de MATE-jeugd. Beta Boeken: Nijmegen; 2013.
56.
Zurück zum Zitat Gold M, Siegel J, Russel L, Weinstein M. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996. Gold M, Siegel J, Russel L, Weinstein M. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
57.
Zurück zum Zitat van der Zanden BP, Dijkgraaf MG, Blanken P, de Borgie CA, van Ree JM, van den Brink W. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug Alcohol Depend. 2006;82(2):111–8.PubMedCrossRef van der Zanden BP, Dijkgraaf MG, Blanken P, de Borgie CA, van Ree JM, van den Brink W. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug Alcohol Depend. 2006;82(2):111–8.PubMedCrossRef
58.
Zurück zum Zitat Pyne JM, French M, McCollister K, Tripathi S, Rapp R, Booth B. Preference-weighted health-related quality of life measures and substance use disorder severity. Addiction. 2008;103(8):1320–9. discussion 1330-2PubMedPubMedCentralCrossRef Pyne JM, French M, McCollister K, Tripathi S, Rapp R, Booth B. Preference-weighted health-related quality of life measures and substance use disorder severity. Addiction. 2008;103(8):1320–9. discussion 1330-2PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Pyne JM, Tripathi S, French M, McCollister K, Rapp RC, Booth BM. Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes. Addiction. 2011;106(3):507–15.PubMedPubMedCentralCrossRef Pyne JM, Tripathi S, French M, McCollister K, Rapp RC, Booth BM. Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes. Addiction. 2011;106(3):507–15.PubMedPubMedCentralCrossRef
1.
Zurück zum Zitat Armelius BA, Andreassen TH. Cognitive-behavioral treatment for antisocial behavior in youth in residential treatment. Cochrane Database Syst Rev. 2007;4(4):CD005650. Armelius BA, Andreassen TH. Cognitive-behavioral treatment for antisocial behavior in youth in residential treatment. Cochrane Database Syst Rev. 2007;4(4):CD005650.
2.
Zurück zum Zitat Arnold EM, Kirk RS, Roberts AC, Griffith DP, Meadows K, Julian J. Treatment of incarcerated, sexually-abused adolescent females: an outcome study. J Child Sex Abus. 2003;12(1):123–39.PubMedCrossRef Arnold EM, Kirk RS, Roberts AC, Griffith DP, Meadows K, Julian J. Treatment of incarcerated, sexually-abused adolescent females: an outcome study. J Child Sex Abus. 2003;12(1):123–39.PubMedCrossRef
3.
Zurück zum Zitat Azzopardi PS, Kennedy EC, Patton GC, Power R, Roseby RD, Sawyer SM, et al. The quality of health research for young Indigenous Australians: systematic review. Med J Aust. 2013;199(1):57–63.PubMedCrossRef Azzopardi PS, Kennedy EC, Patton GC, Power R, Roseby RD, Sawyer SM, et al. The quality of health research for young Indigenous Australians: systematic review. Med J Aust. 2013;199(1):57–63.PubMedCrossRef
4.
Zurück zum Zitat Baldwin SA, Christian S, Berkeljon A, Shadish WR. The effects of family therapies for adolescent delinquency and substance abuse: a meta-analysis. J Marital Fam Ther. 2012;38(1):281–304.PubMedCrossRef Baldwin SA, Christian S, Berkeljon A, Shadish WR. The effects of family therapies for adolescent delinquency and substance abuse: a meta-analysis. J Marital Fam Ther. 2012;38(1):281–304.PubMedCrossRef
5.
Zurück zum Zitat Borduin CM. Multisystemic treatment of criminality and violence in adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38(3):242–9.PubMedCrossRef Borduin CM. Multisystemic treatment of criminality and violence in adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38(3):242–9.PubMedCrossRef
6.
Zurück zum Zitat Borduin CM. Multisystemic treatment of criminality and violence in adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38(3):242–9.PubMedCrossRef Borduin CM. Multisystemic treatment of criminality and violence in adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38(3):242–9.PubMedCrossRef
7.
Zurück zum Zitat Borduin CM, Schaeffer CM, Heiblum N. A randomized clinical trial of multisystemic therapy with juvenile sexual offenders: effects on youth social ecology and criminal activity. J Consult Clin Psychol. 2009;77(1):26–37.PubMedCrossRef Borduin CM, Schaeffer CM, Heiblum N. A randomized clinical trial of multisystemic therapy with juvenile sexual offenders: effects on youth social ecology and criminal activity. J Consult Clin Psychol. 2009;77(1):26–37.PubMedCrossRef
8.
Zurück zum Zitat Brown SA, D'Amico EJ. Outcomes of alcohol treatment for adolescents. Recent Dev Alcohol. 2003;16:289–312.PubMed Brown SA, D'Amico EJ. Outcomes of alcohol treatment for adolescents. Recent Dev Alcohol. 2003;16:289–312.PubMed
9.
Zurück zum Zitat Brown SA, D'Amico EJ, McCarthy DM, Tapert SF. Four-year outcomes from adolescent alcohol and drug treatment. J Stud Alcohol. 2001;62(3):381–8.PubMedCrossRef Brown SA, D'Amico EJ, McCarthy DM, Tapert SF. Four-year outcomes from adolescent alcohol and drug treatment. J Stud Alcohol. 2001;62(3):381–8.PubMedCrossRef
10.
Zurück zum Zitat Burleson JA, Kaminer Y. Self-efficacy as a predictor of treatment outcome in adolescent substance use disorders. Addict Behav. 2005;30(9):1751–64.PubMedCrossRef Burleson JA, Kaminer Y. Self-efficacy as a predictor of treatment outcome in adolescent substance use disorders. Addict Behav. 2005;30(9):1751–64.PubMedCrossRef
11.
Zurück zum Zitat Chamberlain P, Leve LD, Degarmo DS. Multidimensional treatment foster care for girls in the juvenile justice system: 2-year follow-up of a randomized clinical trial. J Consult Clin Psychol. 2007;75(1):187–93.PubMedCrossRef Chamberlain P, Leve LD, Degarmo DS. Multidimensional treatment foster care for girls in the juvenile justice system: 2-year follow-up of a randomized clinical trial. J Consult Clin Psychol. 2007;75(1):187–93.PubMedCrossRef
12.
Zurück zum Zitat Cornelius JR, Douaihy A, Bukstein OG, Daley DC, Wood SD, Kelly TM, et al. Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents. Addict Behav. 2011;36(8):843–8.PubMedPubMedCentralCrossRef Cornelius JR, Douaihy A, Bukstein OG, Daley DC, Wood SD, Kelly TM, et al. Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents. Addict Behav. 2011;36(8):843–8.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Cottrell D, Boston P. Practitioner review: the effectiveness of systemic family therapy for children and adolescents. J Child Psychol Psychiatry. 2002;43(5):573–86.PubMedCrossRef Cottrell D, Boston P. Practitioner review: the effectiveness of systemic family therapy for children and adolescents. J Child Psychol Psychiatry. 2002;43(5):573–86.PubMedCrossRef
14.
Zurück zum Zitat Curtis NM, Ronan KR, Borduin CM. Multisystemic treatment: a meta-analysis of outcome studies. Journal of family. 2004;18(3):411–9. Curtis NM, Ronan KR, Borduin CM. Multisystemic treatment: a meta-analysis of outcome studies. Journal of family. 2004;18(3):411–9.
15.
Zurück zum Zitat D'Amico EJ, Ellickson PL, Wagner EF, Turrisi R, Fromme K, Ghosh-Dastidar B, et al. Developmental considerations for substance use interventions from middle school through college. Alcohol Clin Exp Res. 2005;29(3):474–83.PubMedCrossRef D'Amico EJ, Ellickson PL, Wagner EF, Turrisi R, Fromme K, Ghosh-Dastidar B, et al. Developmental considerations for substance use interventions from middle school through college. Alcohol Clin Exp Res. 2005;29(3):474–83.PubMedCrossRef
16.
Zurück zum Zitat Deas D. Evidence-based treatments for alcohol use disorders in adolescents. Pediatrics. 2008;121(Suppl 4):S348–54.PubMedCrossRef Deas D. Evidence-based treatments for alcohol use disorders in adolescents. Pediatrics. 2008;121(Suppl 4):S348–54.PubMedCrossRef
17.
Zurück zum Zitat Deas D, Thomas SE. An overview of controlled studies of adolescent substance abuse treatment. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2001;10(2):178–89. Deas D, Thomas SE. An overview of controlled studies of adolescent substance abuse treatment. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2001;10(2):178–89.
18.
Zurück zum Zitat Dembo R, Shemwell M, Guida J, Schmeidler J, Pacheco K, Seeberger W. A Longitudinal Study of the Impact of a Family Empowerment Intervention on Juvenile Offender Psychosocial Functioning: A First Assessment. J Child Adolesc Subst Abuse. 1998;8(1):15–54.CrossRef Dembo R, Shemwell M, Guida J, Schmeidler J, Pacheco K, Seeberger W. A Longitudinal Study of the Impact of a Family Empowerment Intervention on Juvenile Offender Psychosocial Functioning: A First Assessment. J Child Adolesc Subst Abuse. 1998;8(1):15–54.CrossRef
19.
Zurück zum Zitat Dembo R, Wothke W, Livingston S, Schmeidler J. The impact of a family empowerment intervention on juvenile offender heavy drinking: a latent growth model analysis. Subst Use Misuse. 2002;37(11):1359–90.PubMedCrossRef Dembo R, Wothke W, Livingston S, Schmeidler J. The impact of a family empowerment intervention on juvenile offender heavy drinking: a latent growth model analysis. Subst Use Misuse. 2002;37(11):1359–90.PubMedCrossRef
20.
Zurück zum Zitat Dennis M, Godley SH, Diamond G, Tims FM, Babor T, Donaldson J, et al. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J Subst Abus Treat. 2004;27(3):197–213.CrossRef Dennis M, Godley SH, Diamond G, Tims FM, Babor T, Donaldson J, et al. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J Subst Abus Treat. 2004;27(3):197–213.CrossRef
21.
Zurück zum Zitat Dennis M, Titus JC, Diamond G, Donaldson J, Godley SH, Tims FM, et al. The Cannabis Youth Treatment (CYT) experiment: rationale, study design and analysis plans. Addiction. 2002;97(Suppl 1):16–34.PubMedCrossRef Dennis M, Titus JC, Diamond G, Donaldson J, Godley SH, Tims FM, et al. The Cannabis Youth Treatment (CYT) experiment: rationale, study design and analysis plans. Addiction. 2002;97(Suppl 1):16–34.PubMedCrossRef
22.
Zurück zum Zitat Diamond G, Josephson A. Family-based treatment research: a 10-year update. J Am Acad Child Adolesc Psychiatry. 2005;44(9):872–87.PubMedCrossRef Diamond G, Josephson A. Family-based treatment research: a 10-year update. J Am Acad Child Adolesc Psychiatry. 2005;44(9):872–87.PubMedCrossRef
23.
Zurück zum Zitat Ferguson LM, Wormith JS. A meta-analysis of moral reconation therapy. Int J Offender Ther Comp Criminol. 2012; Ferguson LM, Wormith JS. A meta-analysis of moral reconation therapy. Int J Offender Ther Comp Criminol. 2012;
24.
Zurück zum Zitat Gil AG, Wagner EF, Tubman JG. Culturally sensitive substance abuse intervention for Hispanic and African American adolescents: empirical examples from the Alcohol Treatment Targeting Adolescents in Need (ATTAIN) Project. Addiction. 2004;99(Suppl 2):140–50.PubMedCrossRef Gil AG, Wagner EF, Tubman JG. Culturally sensitive substance abuse intervention for Hispanic and African American adolescents: empirical examples from the Alcohol Treatment Targeting Adolescents in Need (ATTAIN) Project. Addiction. 2004;99(Suppl 2):140–50.PubMedCrossRef
25.
Zurück zum Zitat Glisson C, Schoenwald SK, Hemmelgarn A, Green P, Dukes D, Armstrong KS, et al. Randomized trial of MST and ARC in a two-level evidence-based treatment implementation strategy. J Consult Clin Psychol. 2010;78(4):537–50.PubMedPubMedCentralCrossRef Glisson C, Schoenwald SK, Hemmelgarn A, Green P, Dukes D, Armstrong KS, et al. Randomized trial of MST and ARC in a two-level evidence-based treatment implementation strategy. J Consult Clin Psychol. 2010;78(4):537–50.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Godley SH, Garner BR, Passetti LL, Funk RR, Dennis ML, Godley MD. Adolescent outpatient treatment and continuing care: main findings from a randomized clinical trial. Drug Alcohol Depend. 2010;110(1–2):44–54.PubMedPubMedCentralCrossRef Godley SH, Garner BR, Passetti LL, Funk RR, Dennis ML, Godley MD. Adolescent outpatient treatment and continuing care: main findings from a randomized clinical trial. Drug Alcohol Depend. 2010;110(1–2):44–54.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Godley SH, Hedges K, Hunter B. Gender and racial differences in treatment process and outcome among participants in the adolescent community reinforcement approach. Psychol Addict Behav. 2011;25(1):143–54.PubMedCrossRef Godley SH, Hedges K, Hunter B. Gender and racial differences in treatment process and outcome among participants in the adolescent community reinforcement approach. Psychol Addict Behav. 2011;25(1):143–54.PubMedCrossRef
28.
Zurück zum Zitat Hall JA, Smith DC, Easton SD, An H, Williams JK, Godley SH, et al. Substance abuse treatment with rural adolescents: issues and outcomes. J Psychoactive Drugs. 2008;40(1):109–20.PubMedCrossRef Hall JA, Smith DC, Easton SD, An H, Williams JK, Godley SH, et al. Substance abuse treatment with rural adolescents: issues and outcomes. J Psychoactive Drugs. 2008;40(1):109–20.PubMedCrossRef
29.
Zurück zum Zitat Harold GT, Kerr DC, Van Ryzin M, Degarmo DS, Rhoades KA, Leve LD. Depressive Symptom Trajectories Among Girls in the Juvenile Justice System: 24-month Outcomes of an RCT of Multidimensional Treatment Foster Care. Prev Sci. 2013; Harold GT, Kerr DC, Van Ryzin M, Degarmo DS, Rhoades KA, Leve LD. Depressive Symptom Trajectories Among Girls in the Juvenile Justice System: 24-month Outcomes of an RCT of Multidimensional Treatment Foster Care. Prev Sci. 2013;
30.
Zurück zum Zitat Henderson CE, Dakof GA, Greenbaum PE, Liddle HA. Effectiveness of multidimensional family therapy with higher severity substance-abusing adolescents: report from two randomized controlled trials. J Consult Clin Psychol. 2010;78(6):885–97.PubMedPubMedCentralCrossRef Henderson CE, Dakof GA, Greenbaum PE, Liddle HA. Effectiveness of multidimensional family therapy with higher severity substance-abusing adolescents: report from two randomized controlled trials. J Consult Clin Psychol. 2010;78(6):885–97.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Henggeler SW, Halliday-Boykins CA, Cunningham PB, Randall J, Shapiro SB, Chapman JE. Juvenile drug court: enhancing outcomes by integrating evidence-based treatments. J Consult Clin Psychol. 2006;74(1):42–54.PubMedCrossRef Henggeler SW, Halliday-Boykins CA, Cunningham PB, Randall J, Shapiro SB, Chapman JE. Juvenile drug court: enhancing outcomes by integrating evidence-based treatments. J Consult Clin Psychol. 2006;74(1):42–54.PubMedCrossRef
32.
Zurück zum Zitat Henggeler SW, McCart MR, Cunningham PB, Chapman JE. Enhancing the effectiveness of juvenile drug courts by integrating evidence-based practices. J Consult Clin Psychol. 2012;80(2):264–75.PubMedPubMedCentralCrossRef Henggeler SW, McCart MR, Cunningham PB, Chapman JE. Enhancing the effectiveness of juvenile drug courts by integrating evidence-based practices. J Consult Clin Psychol. 2012;80(2):264–75.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Henggeler SW, Melton GB, Brondino MJ, Scherer DG, Hanley JH. Multisystemic therapy with violent and chronic juvenile offenders and their families: the role of treatment fidelity in successful dissemination. J Consult Clin Psychol. 1997;65(5):821–33.PubMedCrossRef Henggeler SW, Melton GB, Brondino MJ, Scherer DG, Hanley JH. Multisystemic therapy with violent and chronic juvenile offenders and their families: the role of treatment fidelity in successful dissemination. J Consult Clin Psychol. 1997;65(5):821–33.PubMedCrossRef
34.
Zurück zum Zitat Henggeler SW, Melton GB, Smith LA. Family preservation using multisystemic therapy: an effective alternative to incarcerating serious juvenile offenders. J Consult Clin Psychol. 1992;60(6):953–61.PubMedCrossRef Henggeler SW, Melton GB, Smith LA. Family preservation using multisystemic therapy: an effective alternative to incarcerating serious juvenile offenders. J Consult Clin Psychol. 1992;60(6):953–61.PubMedCrossRef
35.
Zurück zum Zitat Henggeler SW, Pickrel SG, Brondino MJ. Multisystemic treatment of substance-abusing and dependent delinquents: outcomes, treatment fidelity, and transportability. Ment Health Serv Res. 1999;1(3):171–84.PubMedCrossRef Henggeler SW, Pickrel SG, Brondino MJ. Multisystemic treatment of substance-abusing and dependent delinquents: outcomes, treatment fidelity, and transportability. Ment Health Serv Res. 1999;1(3):171–84.PubMedCrossRef
36.
Zurück zum Zitat Henggeler SW, Sheidow AJ. Empirically supported family-based treatments for conduct disorder and delinquency in adolescents. J Marital Fam Ther. 2012;38(1):30–58.PubMedCrossRef Henggeler SW, Sheidow AJ. Empirically supported family-based treatments for conduct disorder and delinquency in adolescents. J Marital Fam Ther. 2012;38(1):30–58.PubMedCrossRef
37.
Zurück zum Zitat Henggeler SW, Sheidow AJ. Conduct disorder and delinquency. J Marital Fam Ther. 2003;29(4):505–22.PubMedCrossRef Henggeler SW, Sheidow AJ. Conduct disorder and delinquency. J Marital Fam Ther. 2003;29(4):505–22.PubMedCrossRef
38.
Zurück zum Zitat Hogue A, Dauber S, Stambaugh LF, Cecero JJ, Liddle HA. Early therapeutic alliance and treatment outcome in individual and family therapy for adolescent behavior problems. J Consult Clin Psychol. 2006;74(1):121–9.PubMedPubMedCentralCrossRef Hogue A, Dauber S, Stambaugh LF, Cecero JJ, Liddle HA. Early therapeutic alliance and treatment outcome in individual and family therapy for adolescent behavior problems. J Consult Clin Psychol. 2006;74(1):121–9.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Hogue A, Henderson CE, Dauber S, Barajas PC, Fried A, Liddle HA. Treatment adherence, competence, and outcome in individual and family therapy for adolescent behavior problems. J Consult Clin Psychol. 2008;76(4):544–55.PubMedPubMedCentralCrossRef Hogue A, Henderson CE, Dauber S, Barajas PC, Fried A, Liddle HA. Treatment adherence, competence, and outcome in individual and family therapy for adolescent behavior problems. J Consult Clin Psychol. 2008;76(4):544–55.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Hogue A, Liddle HA. Family-based treatment for adolescent substance abuse: controlled trials and new horizons in services research. J Fam Ther. 2009;31(2):126–54.PubMedPubMedCentralCrossRef Hogue A, Liddle HA. Family-based treatment for adolescent substance abuse: controlled trials and new horizons in services research. J Fam Ther. 2009;31(2):126–54.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Hunter SB, Ramchand R, Griffin BA, Suttorp MJ, McCaffrey D, Morral A. The effectiveness of community-based delivery of an evidence-based treatment for adolescent substance use. J Subst Abus Treat. 2012;43(2):211–20.CrossRef Hunter SB, Ramchand R, Griffin BA, Suttorp MJ, McCaffrey D, Morral A. The effectiveness of community-based delivery of an evidence-based treatment for adolescent substance use. J Subst Abus Treat. 2012;43(2):211–20.CrossRef
42.
Zurück zum Zitat Kaminer Y, Burleson JA. Does temperament moderate treatment response in adolescent substance use disorders? Subst Abus. 2008;29(2):89–95.CrossRef Kaminer Y, Burleson JA. Does temperament moderate treatment response in adolescent substance use disorders? Subst Abus. 2008;29(2):89–95.CrossRef
43.
Zurück zum Zitat Kaminer Y, Burleson JA, Goldberger R. Cognitive-behavioral coping skills and psychoeducation therapies for adolescent substance abuse. J Nerv Ment Dis. 2002;190(11):737–45.PubMedCrossRef Kaminer Y, Burleson JA, Goldberger R. Cognitive-behavioral coping skills and psychoeducation therapies for adolescent substance abuse. J Nerv Ment Dis. 2002;190(11):737–45.PubMedCrossRef
44.
Zurück zum Zitat Kaminer Y, Burleson JA, Goldston DB, Burke RH. Suicidal ideation among adolescents with alcohol use disorders during treatment and aftercare. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2006;15(Suppl 1):43–9. Kaminer Y, Burleson JA, Goldston DB, Burke RH. Suicidal ideation among adolescents with alcohol use disorders during treatment and aftercare. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2006;15(Suppl 1):43–9.
45.
Zurück zum Zitat Keiley MK. Multiple-family group intervention for incarcerated adolescents and their families: a pilot project. J Marital Fam Ther. 2007;33(1):106–24.PubMedCrossRef Keiley MK. Multiple-family group intervention for incarcerated adolescents and their families: a pilot project. J Marital Fam Ther. 2007;33(1):106–24.PubMedCrossRef
46.
Zurück zum Zitat Killeen TK, McRae-Clark AL, Waldrop AE, Upadhyaya H, Brady KT. Contingency management in community programs treating adolescent substance abuse: a feasibility study. J Child Adolesc Psychiatr Nurs. 2012;25(1):33–41.PubMedPubMedCentralCrossRef Killeen TK, McRae-Clark AL, Waldrop AE, Upadhyaya H, Brady KT. Contingency management in community programs treating adolescent substance abuse: a feasibility study. J Child Adolesc Psychiatr Nurs. 2012;25(1):33–41.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Latimer WW, Winters KC, D'Zurilla T, Nichols M. Integrated family and cognitive-behavioral therapy for adolescent substance abusers: a stage I efficacy study. Drug Alcohol Depend. 2003;71(3):303–17.PubMedCrossRef Latimer WW, Winters KC, D'Zurilla T, Nichols M. Integrated family and cognitive-behavioral therapy for adolescent substance abusers: a stage I efficacy study. Drug Alcohol Depend. 2003;71(3):303–17.PubMedCrossRef
48.
Zurück zum Zitat Letourneau EJ, Henggeler SW, Borduin CM, Schewe PA, McCart MR, Chapman JE, et al. Multisystemic therapy for juvenile sexual offenders: 1-year results from a randomized effectiveness trial. J Fam Psychol. 2009;23(1):89–102.PubMedPubMedCentralCrossRef Letourneau EJ, Henggeler SW, Borduin CM, Schewe PA, McCart MR, Chapman JE, et al. Multisystemic therapy for juvenile sexual offenders: 1-year results from a randomized effectiveness trial. J Fam Psychol. 2009;23(1):89–102.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Liddle HA, Dakof GA, Parker K, Diamond GS, Barrett K, Tejeda M. Multidimensional family therapy for adolescent drug abuse: results of a randomized clinical trial. Am J Drug Alcohol Abuse. 2001;27(4):651–88.PubMedCrossRef Liddle HA, Dakof GA, Parker K, Diamond GS, Barrett K, Tejeda M. Multidimensional family therapy for adolescent drug abuse: results of a randomized clinical trial. Am J Drug Alcohol Abuse. 2001;27(4):651–88.PubMedCrossRef
50.
Zurück zum Zitat Liddle HA, Dakof GA, Turner RM, Henderson CE, Greenbaum PE. Treating adolescent drug abuse: a randomized trial comparing multidimensional family therapy and cognitive behavior therapy. Addiction. 2008;103(10):1660–70.PubMedCrossRef Liddle HA, Dakof GA, Turner RM, Henderson CE, Greenbaum PE. Treating adolescent drug abuse: a randomized trial comparing multidimensional family therapy and cognitive behavior therapy. Addiction. 2008;103(10):1660–70.PubMedCrossRef
51.
Zurück zum Zitat Liddle HA, Rowe CL, Dakof GA, Henderson CE, Greenbaum PE. Multidimensional family therapy for young adolescent substance abuse: twelve-month outcomes of a randomized controlled trial. J Consult Clin Psychol. 2009;77(1):12–25.PubMedCrossRef Liddle HA, Rowe CL, Dakof GA, Henderson CE, Greenbaum PE. Multidimensional family therapy for young adolescent substance abuse: twelve-month outcomes of a randomized controlled trial. J Consult Clin Psychol. 2009;77(1):12–25.PubMedCrossRef
52.
Zurück zum Zitat Liddle HA, Rowe CL, Dakof GA, Ungaro RA, Henderson CE. Early intervention for adolescent substance abuse: pretreatment to posttreatment outcomes of a randomized clinical trial comparing multidimensional family therapy and peer group treatment. J Psychoactive Drugs. 2004;36(1):49–63.PubMedCrossRef Liddle HA, Rowe CL, Dakof GA, Ungaro RA, Henderson CE. Early intervention for adolescent substance abuse: pretreatment to posttreatment outcomes of a randomized clinical trial comparing multidimensional family therapy and peer group treatment. J Psychoactive Drugs. 2004;36(1):49–63.PubMedCrossRef
53.
Zurück zum Zitat Littell JH, Popa M, Forsythe B. Multisystemic Therapy for social, emotional, and behavioral problems in youth aged 10-17. Cochrane Database Syst Rev. 2005;4(4):CD004797. Littell JH, Popa M, Forsythe B. Multisystemic Therapy for social, emotional, and behavioral problems in youth aged 10-17. Cochrane Database Syst Rev. 2005;4(4):CD004797.
54.
Zurück zum Zitat Lott DC, Jencius S. Effectiveness of very low-cost contingency management in a community adolescent treatment program. Drug Alcohol Depend. 2009;102(1–3):162–5.PubMedCrossRef Lott DC, Jencius S. Effectiveness of very low-cost contingency management in a community adolescent treatment program. Drug Alcohol Depend. 2009;102(1–3):162–5.PubMedCrossRef
55.
Zurück zum Zitat Marsden J, Stillwell G, Barlow H, Boys A, Taylor C, Hunt N, et al. An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes. Addiction. 2006;101(7):1014–26.PubMedCrossRef Marsden J, Stillwell G, Barlow H, Boys A, Taylor C, Hunt N, et al. An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes. Addiction. 2006;101(7):1014–26.PubMedCrossRef
56.
Zurück zum Zitat Martin G, Copeland J. The adolescent cannabis check-up: randomized trial of a brief intervention for young cannabis users. J Subst Abus Treat. 2008;34(4):407–14.CrossRef Martin G, Copeland J. The adolescent cannabis check-up: randomized trial of a brief intervention for young cannabis users. J Subst Abus Treat. 2008;34(4):407–14.CrossRef
57.
Zurück zum Zitat McCambridge J, Strang J. The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction. 2004;99(1):39–52.PubMedCrossRef McCambridge J, Strang J. The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction. 2004;99(1):39–52.PubMedCrossRef
58.
Zurück zum Zitat McGlynn AH, Hahn P, Hagan MP. The Effect of a Cognitive Treatment Program for Male and Female Juvenile Offenders. Int J Offender Ther Comp Criminol. 2012; McGlynn AH, Hahn P, Hagan MP. The Effect of a Cognitive Treatment Program for Male and Female Juvenile Offenders. Int J Offender Ther Comp Criminol. 2012;
59.
Zurück zum Zitat Moore SK, Marsch LA, Badger GJ, Solhkhah R, Hofstein Y. Improvement in psychopathology among opioid-dependent adolescents during behavioral-pharmacological treatment. J Addict Med. 2011;5(4):264–71.PubMedPubMedCentralCrossRef Moore SK, Marsch LA, Badger GJ, Solhkhah R, Hofstein Y. Improvement in psychopathology among opioid-dependent adolescents during behavioral-pharmacological treatment. J Addict Med. 2011;5(4):264–71.PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Randall J, Cunningham PB. Multisystemic therapy: a treatment for violent substance-abusing and substance-dependent juvenile offenders. Addict Behav. 2003;28(9):1731–9.PubMedCrossRef Randall J, Cunningham PB. Multisystemic therapy: a treatment for violent substance-abusing and substance-dependent juvenile offenders. Addict Behav. 2003;28(9):1731–9.PubMedCrossRef
61.
Zurück zum Zitat Rigter H, Henderson CE, Pelc I, Tossmann P, Phan O, Hendriks V, et al. Multidimensional family therapy lowers the rate of cannabis dependence in adolescents: a randomised controlled trial in Western European outpatient settings. Drug Alcohol Depend. 2013;130(1–3):85–93.PubMedCrossRef Rigter H, Henderson CE, Pelc I, Tossmann P, Phan O, Hendriks V, et al. Multidimensional family therapy lowers the rate of cannabis dependence in adolescents: a randomised controlled trial in Western European outpatient settings. Drug Alcohol Depend. 2013;130(1–3):85–93.PubMedCrossRef
62.
Zurück zum Zitat Robbins MS, Feaster DJ, Horigian VE, Rohrbaugh M, Shoham V, Bachrach K, et al. Brief strategic family therapy versus treatment as usual: results of a multisite randomized trial for substance using adolescents. J Consult Clin Psychol. 2011;79(6):713–27.PubMedPubMedCentralCrossRef Robbins MS, Feaster DJ, Horigian VE, Rohrbaugh M, Shoham V, Bachrach K, et al. Brief strategic family therapy versus treatment as usual: results of a multisite randomized trial for substance using adolescents. J Consult Clin Psychol. 2011;79(6):713–27.PubMedPubMedCentralCrossRef
63.
Zurück zum Zitat Robbins MS, Szapocznik J, Dillon FR, Turner CW, Mitrani VB, Feaster DJ. The efficacy of structural ecosystems therapy with drug-abusing/dependent African American and Hispanic American adolescents. J Fam Psychol. 2008;22(1):51–61.PubMedCrossRef Robbins MS, Szapocznik J, Dillon FR, Turner CW, Mitrani VB, Feaster DJ. The efficacy of structural ecosystems therapy with drug-abusing/dependent African American and Hispanic American adolescents. J Fam Psychol. 2008;22(1):51–61.PubMedCrossRef
64.
Zurück zum Zitat Rohde P, Jorgensen JS, Seeley JR, Mace DE. Pilot evaluation of the Coping Course: a cognitive-behavioral intervention to enhance coping skills in incarcerated youth. J Am Acad Child Adolesc Psychiatry. 2004;43(6):669–76.PubMedCrossRef Rohde P, Jorgensen JS, Seeley JR, Mace DE. Pilot evaluation of the Coping Course: a cognitive-behavioral intervention to enhance coping skills in incarcerated youth. J Am Acad Child Adolesc Psychiatry. 2004;43(6):669–76.PubMedCrossRef
65.
Zurück zum Zitat Sealock M, Gottfredson D, Gallagher C. Drug Treatment for Juvenile Offenders: Some Good and Bad News. J Res Crime Delinq. 1997;34(2):210–36.CrossRef Sealock M, Gottfredson D, Gallagher C. Drug Treatment for Juvenile Offenders: Some Good and Bad News. J Res Crime Delinq. 1997;34(2):210–36.CrossRef
66.
Zurück zum Zitat Sexton T, Turner CW. The effectiveness of functional family therapy for youth with behavioral problems in a community practice setting. J Fam Psychol. 2010;24(3):339–48.PubMedPubMedCentralCrossRef Sexton T, Turner CW. The effectiveness of functional family therapy for youth with behavioral problems in a community practice setting. J Fam Psychol. 2010;24(3):339–48.PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat Smith DC, Hall JA, Williams JK, An H, Gotman N. Comparative efficacy of family and group treatment for adolescent substance abuse. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2006;15(Suppl 1):131–6. Smith DC, Hall JA, Williams JK, An H, Gotman N. Comparative efficacy of family and group treatment for adolescent substance abuse. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2006;15(Suppl 1):131–6.
68.
Zurück zum Zitat Tanner-Smith EE, Wilson SJ, Lipsey MW. The comparative effectiveness of outpatient treatment for adolescent substance abuse: a meta-analysis. J Subst Abus Treat. 2013;44(2):145–58.CrossRef Tanner-Smith EE, Wilson SJ, Lipsey MW. The comparative effectiveness of outpatient treatment for adolescent substance abuse: a meta-analysis. J Subst Abus Treat. 2013;44(2):145–58.CrossRef
69.
Zurück zum Zitat Timmons-Mitchell J, Bender MB, Kishna MA, Mitchell CC. An independent effectiveness trial of multisystemic therapy with juvenile justice youth. J Clin Child Adolesc Psychol. 2006;35(2):227–36.PubMedCrossRef Timmons-Mitchell J, Bender MB, Kishna MA, Mitchell CC. An independent effectiveness trial of multisystemic therapy with juvenile justice youth. J Clin Child Adolesc Psychol. 2006;35(2):227–36.PubMedCrossRef
70.
Zurück zum Zitat Tripodi SJ, Bender K, Litschge C, Vaughn MG. Interventions for reducing adolescent alcohol abuse: a meta-analytic review. Arch Pediatr Adolesc Med. 2010;164(1):85–91.PubMedCrossRef Tripodi SJ, Bender K, Litschge C, Vaughn MG. Interventions for reducing adolescent alcohol abuse: a meta-analytic review. Arch Pediatr Adolesc Med. 2010;164(1):85–91.PubMedCrossRef
71.
Zurück zum Zitat Waldron HB, Kaminer Y. On the learning curve: the emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse. Addiction. 2004;99(Suppl 2):93–105.PubMedPubMedCentralCrossRef Waldron HB, Kaminer Y. On the learning curve: the emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse. Addiction. 2004;99(Suppl 2):93–105.PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Waldron HB, Kern-Jones S, Turner CW, Peterson TR, Ozechowski TJ. Engaging resistant adolescents in drug abuse treatment. J Subst Abus Treat. 2007;32(2):133–42.CrossRef Waldron HB, Kern-Jones S, Turner CW, Peterson TR, Ozechowski TJ. Engaging resistant adolescents in drug abuse treatment. J Subst Abus Treat. 2007;32(2):133–42.CrossRef
73.
Zurück zum Zitat Waldron HB, Slesnick N, Brody JL, Turner CW, Peterson TR. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol. 2001;69(5):802–13.PubMedCrossRef Waldron HB, Slesnick N, Brody JL, Turner CW, Peterson TR. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol. 2001;69(5):802–13.PubMedCrossRef
74.
Zurück zum Zitat Waldron HB, Turner CW. Evidence-based psychosocial treatments for adolescent substance abuse. Journal of clinical child and adolescent. 2008;37(1):238–61.CrossRef Waldron HB, Turner CW. Evidence-based psychosocial treatments for adolescent substance abuse. Journal of clinical child and adolescent. 2008;37(1):238–61.CrossRef
75.
Zurück zum Zitat Walker DD, Stephens R, Roffman R, Demarce J, Lozano B, Towe S, et al. Randomized controlled trial of motivational enhancement therapy with nontreatment-seeking adolescent cannabis users: a further test of the teen marijuana check-up. Psychol Addict Behav. 2011;25(3):474–84.PubMedPubMedCentralCrossRef Walker DD, Stephens R, Roffman R, Demarce J, Lozano B, Towe S, et al. Randomized controlled trial of motivational enhancement therapy with nontreatment-seeking adolescent cannabis users: a further test of the teen marijuana check-up. Psychol Addict Behav. 2011;25(3):474–84.PubMedPubMedCentralCrossRef
76.
Zurück zum Zitat Walker DF, McGovern SK, Poey EL, Otis KE. Treatment effectiveness for male adolescent sexual offenders: a meta-analysis and review. J Child Sex Abus. 2004;13(3–4):281–93.PubMedCrossRef Walker DF, McGovern SK, Poey EL, Otis KE. Treatment effectiveness for male adolescent sexual offenders: a meta-analysis and review. J Child Sex Abus. 2004;13(3–4):281–93.PubMedCrossRef
77.
Zurück zum Zitat Winters KC, Fahnhorst T, Botzet A, Lee S, Lalone B. Brief intervention for drug-abusing adolescents in a school setting: outcomes and mediating factors. J Subst Abus Treat. 2012;42(3):279–88.CrossRef Winters KC, Fahnhorst T, Botzet A, Lee S, Lalone B. Brief intervention for drug-abusing adolescents in a school setting: outcomes and mediating factors. J Subst Abus Treat. 2012;42(3):279–88.CrossRef
78.
Zurück zum Zitat Winters KC, Leitten W. Brief intervention for drug-abusing adolescents in a school setting. Psychol Addict Behav. 2007;21(2):249–54.PubMedCrossRef Winters KC, Leitten W. Brief intervention for drug-abusing adolescents in a school setting. Psychol Addict Behav. 2007;21(2):249–54.PubMedCrossRef
79.
Zurück zum Zitat Winters KC, Stinchfield RD, Opland E, Weller C, Latimer WW. The effectiveness of the Minnesota Model approach in the treatment of adolescent drug abusers. Addiction. 2000;95(4):601–12.PubMedCrossRef Winters KC, Stinchfield RD, Opland E, Weller C, Latimer WW. The effectiveness of the Minnesota Model approach in the treatment of adolescent drug abusers. Addiction. 2000;95(4):601–12.PubMedCrossRef
80.
Zurück zum Zitat Woolfenden SR, Williams K, Peat J. Family and parenting interventions in children and adolescents with conduct disorder and delinquency aged 10-17. Cochrane Database Syst Rev. 2001;2(2):CD003015. Woolfenden SR, Williams K, Peat J. Family and parenting interventions in children and adolescents with conduct disorder and delinquency aged 10-17. Cochrane Database Syst Rev. 2001;2(2):CD003015.
Metadaten
Titel
The search for relevant outcome measures for cost-utility analysis of systemic family interventions in adolescents with substance use disorder and delinquent behavior: a systematic literature review
verfasst von
S. Schawo
C. Bouwmans
E. van der Schee
V. Hendriks
W. Brouwer
L. Hakkaart
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
Health and Quality of Life Outcomes / Ausgabe 1/2017
Elektronische ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-017-0722-9

Weitere Artikel der Ausgabe 1/2017

Health and Quality of Life Outcomes 1/2017 Zur Ausgabe